delta.rank,pval,level,nseqs,term,name,p.adj
0,1.75E-15,5,3804,unknown,unknown,0
0,0.002797229,2,69,GO:0046649;GO:0045321,leukocyte activation,0.728947368
0,0.002797009,2,16,GO:0006672,ceramide metabolic process,0.769444444
0,0.002768138,5,5,GO:0015809;GO:0015802,arginine transport,0.808823529
0,0.00331657,2,48,GO:0051865,protein autoubiquitination,0.81
0,0.004062496,2,410,GO:0010629;GO:0010605;GO:0009892,negative regulation of metabolic process,0.827083333
0,0.002749238,3,20,GO:0006109;GO:0043467,regulation of carbohydrate metabolic process,0.85
0,0.003989512,2,599,GO:0006996,organelle organization,0.85
0,0.004968087,2,666,GO:0048869,cellular developmental process,0.871428571
0,0.005353338,2,33,GO:0090305,nucleic acid phosphodiester bond hydrolysis,0.876666667
0,0.003822298,2,21,GO:0002700,regulation of production of molecular mediator of immune response,0.883333333
0,0.003979444,4,275,GO:0007010,cytoskeleton organization,0.884090909
0,0.005263102,5,10,GO:0006265,DNA topological change,0.887931034
0,0.019540627,2,5,GO:0007016,cytoskeletal anchoring at plasma membrane,0.888425926
0,0.019540627,4,5,GO:0007159,leukocyte cell-cell adhesion,0.888425926
0,0.020964896,3,6,GO:0036230;GO:0042119;GO:0030854;GO:0030852,granulocyte activation,0.889473684
0,0.020964896,3,6,GO:0048384,retinoic acid receptor signaling pathway,0.889473684
0,0.024154494,2,38,GO:0030522,intracellular receptor signaling pathway,0.889694656
0,0.002720483,3,458,GO:0030154,cell differentiation,0.89
0,0.006811301,2,43,GO:0062012,regulation of small molecule metabolic process,0.890277778
0,0.004731118,2,20,GO:0050777,negative regulation of immune response,0.890384615
0,0.015662307,3,7,GO:0062014,negative regulation of small molecule metabolic process,0.891176471
0,0.023999017,2,108,GO:0001775,cell activation,0.891923077
0,0.015534517,4,98,GO:0071310,cellular response to organic substance,0.892857143
0,0.023894699,3,7,GO:0002443,leukocyte mediated immunity,0.89496124
0,0.021934191,4,67,GO:1901701,cellular response to oxygen-containing compound,0.895338983
0,0.00494257,2,58,GO:0000910,cytokinesis,0.896296296
0,0.018468494,2,39,GO:0007041;GO:0007034,vacuolar transport,0.896534653
0,0.021272198,3,11,GO:0007617;GO:0019098,reproductive behavior,0.897391304
0,0.004647943,8,29,GO:0051403;GO:0031098,stress-activated MAPK cascade,0.898
0,0.020043406,2,6,GO:0046627;GO:1900077,negative regulation of insulin receptor signaling pathway,0.899082569
0,0.020799523,4,67,GO:0043161;GO:0010498,proteasome-mediated ubiquitin-dependent protein catabolic process,0.899553571
0,0.020325114,7,7,GO:0048008,platelet-derived growth factor receptor signaling pathway,0.9
0,0.015500175,3,38,GO:0043414;GO:0032259,macromolecule methylation,0.901204819
0,0.019222603,3,14,GO:0042752,regulation of circadian rhythm,0.901428571
0,0.023885159,2,82,GO:0031347,regulation of defense response,0.9015625
0,0.021915957,3,11,GO:0032715,negative regulation of interleukin-6 production,0.902136752
0,0.021915957,6,11,GO:0051769,regulation of nitric-oxide synthase biosynthetic process,0.902136752
0,0.015280912,6,7,GO:0005979;GO:0010962;GO:0070873;GO:0032885;GO:0032881,regulation of glucan biosynthetic process,0.902439024
0,0.015280912,2,7,GO:0006983,ER overload response,0.902439024
0,0.015280912,2,7,GO:0032869;GO:0046324,cellular response to insulin stimulus,0.902439024
0,0.02477353,4,13,GO:0071375;GO:1901653,cellular response to peptide,0.902631579
0,0.024665067,2,9,GO:0033157;GO:1903827,regulation of cellular protein localization,0.903030303
0,0.025481731,7,17,GO:0002756;GO:0034138,toll-like receptor 3 signaling pathway,0.903308824
0,0.018099719,3,8,GO:0019884;GO:0002478,antigen processing and presentation of exogenous antigen,0.903571429
0,0.018099719,2,8,GO:0032735;GO:0002833,positive regulation of interleukin-12 production,0.903571429
0,0.019485411,2,50,GO:1903706,regulation of hemopoiesis,0.903773585
0,0.01909016,5,14,GO:0030866;GO:0030865,cortical cytoskeleton organization,0.904326923
0,0.018437383,2,14,GO:0051017;GO:0061572,actin filament bundle assembly,0.9045
0,0.0171761,3,446,GO:0016192,vesicle-mediated transport,0.90483871
0,0.018302801,5,9,GO:0031929,TOR signaling,0.905050505
0,0.023628781,5,7,GO:0046755,viral budding,0.90515873
0,0.023825267,3,8,GO:0019430;GO:0098869;GO:1990748;GO:0098754,cellular oxidant detoxification,0.906299213
0,0.020751088,2,179,GO:1901565,organonitrogen compound catabolic process,0.906306306
0,0.018984679,6,7,GO:0046058,cAMP metabolic process,0.906796117
0,0.016201089,5,29,GO:0032675,regulation of interleukin-6 production,0.907471264
0,0.025461194,4,14,GO:0030032;GO:0097581,lamellipodium assembly,0.909259259
0,0.026198612,3,17,GO:0018298,protein-chromophore linkage,0.910431655
0,0.016104344,3,26,GO:0010212,response to ionizing radiation,0.910465116
0,0.017100756,3,5,GO:0010259,multicellular organism aging,0.911956522
0,0.023614412,5,30,GO:0070663,regulation of leukocyte proliferation,0.912
0,0.006051427,2,101,GO:0000226,microtubule cytoskeleton organization,0.9125
0,0.018958347,7,14,GO:0051453;GO:0030641;GO:0030004,regulation of intracellular pH,0.912745098
0,0.025361912,2,11,GO:0006513,protein monoubiquitination,0.913059701
0,0.02609996,2,14,GO:2000377,regulation of reactive oxygen species metabolic process,0.913405797
0,0.00679861,2,6,GO:0045132,meiotic chromosome segregation,0.914285714
0,0.005843779,2,26,GO:0071396,cellular response to lipid,0.914516129
0,0.017529552,4,10,GO:0006911;GO:0099024;GO:0010324,membrane invagination,0.914893617
0,0.017687899,3,5,GO:0045806;GO:0070086,ubiquitin-dependent endocytosis,0.915263158
0,0.026025219,4,38,GO:0002521,leukocyte differentiation,0.916423358
0,0.023537919,2,15,GO:0009880,embryonic pattern specification,0.916532258
0,0.023537919,2,15,GO:0048640,negative regulation of developmental growth,0.916532258
0,0.017957695,2,61,GO:0002697,regulation of immune effector process,0.916666667
0,0.01706437,4,8,GO:0030970;GO:0032527;GO:1903513,endoplasmic reticulum to cytosol transport,0.919230769
0,0.028232179,2,20,GO:0008361,regulation of cell size,0.923129252
0,0.016661555,2,32,GO:0051051,negative regulation of transport,0.923863636
0,0.016993443,1,53,GO:0048511,rhythmic process,0.923888889
0,0.028078609,2,70,GO:0032147,activation of protein kinase activity,0.923972603
0,0.028607729,2,572,GO:1901575;GO:0009056;GO:0044248,catabolic process,0.924496644
0,0.023317268,3,9,GO:0040001;GO:0051293;GO:0051653,spindle localization,0.924590164
0,0.029353656,2,288,GO:0022402,cell cycle process,0.927960526
0,0.014462132,2,24,GO:0042129;GO:0050670;GO:0032944,regulation of lymphocyte proliferation,0.928
0,0.023146194,4,265,GO:0045892;GO:1903507;GO:2000113;GO:1902679;GO:0010558;GO:0031327;GO:0051253;GO:0009890;GO:0045934,negative regulation of biosynthetic process,0.928099174
0,0.002656556,2,7,GO:0008293,torso signaling pathway,0.928571429
0,0.028048507,4,9,GO:0046626;GO:1900076,regulation of cellular response to insulin stimulus,0.929310345
0,0.006714683,3,285,GO:0010033,response to organic substance,0.929411765
0,0.027304527,4,10,GO:0045075;GO:0032655,regulation of interleukin-12 production,0.929432624
0,0.022872664,2,41,GO:0007059,chromosome segregation,0.929831933
0,0.001768243,4,27,GO:0030099,myeloid cell differentiation,0.93
0,0.028593597,2,20,GO:0007254,JNK cascade,0.930067568
0,0.015205363,2,104,GO:0032989,cellular component morphogenesis,0.930379747
0,0.027056144,2,12,GO:0016574,histone ubiquitination,0.931071429
0,0.027865603,1,325,GO:0002376,immune system process,0.931597222
0,0.014276733,2,771,GO:0006464;GO:0036211;GO:0044267;GO:0043412,cellular protein metabolic process,0.931756757
0,0.016979957,2,46,GO:0007030,Golgi organization,0.93258427
0,0.037611337,2,12,GO:0002573,myeloid leukocyte differentiation,0.933507853
0,0.037611337,2,12,GO:0031664,regulation of lipopolysaccharide-mediated signaling pathway,0.933507853
0,0.02933803,2,9,GO:0030218,erythrocyte differentiation,0.933774834
0,0.01350689,2,397,GO:0042221,response to chemical,0.934057971
0,0.023115,2,508,GO:0051239,regulation of multicellular organismal process,0.934166667
0,0.015096768,4,46,GO:0034976,response to endoplasmic reticulum stress,0.93525641
0,0.037936749,2,7,GO:0048635,negative regulation of muscle organ development,0.935416667
0,0.038222656,3,13,GO:0045176,apical protein localization,0.936010363
0,0.014953438,4,84,GO:0033993,response to lipid,0.937012987
0,0.037305471,2,179,GO:0006955,immune response,0.937301587
0,0.027844196,2,310,GO:0031324;GO:0051172,negative regulation of cellular metabolic process,0.937762238
0,0.001604606,3,28,GO:0070534,protein K63-linked ubiquitination,0.938888889
0,0.029300657,2,86,GO:0051223;GO:0070201;GO:0090087;GO:0032880,regulation of protein localization,0.939
0,0.036312042,2,24,GO:0032870,cellular response to hormone stimulus,0.939402174
0,0.038565376,2,7,GO:0032456,endocytic recycling,0.93943299
0,0.03596618,5,10,GO:0032438;GO:0048753,pigment granule organization,0.93956044
0,0.011804456,2,134,GO:0006897;GO:0098657,import into cell,0.939655172
0,0.01421619,3,5,GO:0000132;GO:0051294,establishment of mitotic spindle orientation,0.94109589
0,0.01421619,4,5,GO:0060487;GO:0060479,lung cell differentiation,0.94109589
0,0.036193021,2,394,GO:0045893;GO:0010628;GO:1903508;GO:1902680;GO:0010557;GO:0031328;GO:0051254;GO:0009891;GO:0045935,positive regulation of biosynthetic process,0.941256831
0,0.037226613,7,22,GO:0002755;GO:0034130;GO:0034134,MyD88-dependent toll-like receptor signaling pathway,0.941489362
0,0.002265157,3,293,GO:0009057;GO:0044265,macromolecule catabolic process,0.941666667
0,0.013407272,3,6,GO:0002862;GO:0002861,regulation of inflammatory response to antigenic stimulus,0.941911765
0,0.013407272,3,6,GO:0034763;GO:0080164,negative regulation of transmembrane transport,0.941911765
0,0.013407272,2,6,GO:0051771,negative regulation of nitric-oxide synthase biosynthetic process,0.941911765
0,0.013407272,2,6,GO:0071222,cellular response to lipopolysaccharide,0.941911765
0,0.027798273,2,203,GO:0051241,negative regulation of multicellular organismal process,0.942605634
0,0.033758365,4,21,GO:0030433;GO:0036503,ERAD pathway,0.942690058
0,0.033427691,5,5,GO:0006414,translational elongation,0.943195266
0,0.034479073,4,21,GO:0043902,positive regulation of multi-organism process,0.943390805
0,0.040133136,2,23,GO:0007033,vacuole organization,0.94375
0,0.006588233,2,22,GO:0030968,endoplasmic reticulum unfolded protein response,0.943939394
0,0.014873816,2,26,GO:0006865,amino acid transport,0.944078947
0,0.040384892,8,11,GO:0051568;GO:0001555,histone H3-K4 methylation,0.944278607
0,0.035960129,2,32,GO:0007162,negative regulation of cell adhesion,0.944751381
0,0.039953797,3,11,GO:0046006,regulation of activated T cell proliferation,0.944974874
0,0.039953797,2,11,GO:0050856;GO:0050854,regulation of T cell receptor signaling pathway,0.944974874
0,0.039014937,3,5,GO:0002639,positive regulation of immunoglobulin production,0.945384615
0,0.034327521,3,172,GO:1901700,response to oxygen-containing compound,0.946242775
0,0.037194996,7,7,GO:0006102,isocitrate metabolic process,0.946256684
0,0.033268686,2,13,GO:0016925,protein sumoylation,0.946428571
0,0.035868044,7,37,GO:0008286,insulin receptor signaling pathway,0.946666667
0,0.03374088,3,5,GO:0085020,protein K6-linked ubiquitination,0.947941176
0,0.039600255,2,10,GO:0048745,smooth muscle tissue development,0.948477157
0,0.035795891,2,13,GO:0030183,B cell differentiation,0.948882682
0,0.036918474,2,18,GO:0060021,roof of mouth development,0.949189189
0,0.033208012,3,133,GO:0070887,cellular response to chemical stimulus,0.95
0,0.034269892,2,11,GO:0002763;GO:0002761,positive regulation of myeloid leukocyte differentiation,0.951162791
0,0.037186144,2,17,GO:1901570,fatty acid derivative biosynthetic process,0.951344086
0,0.035659836,2,136,GO:0050776,regulation of immune response,0.951404494
0,0.039546916,3,6,GO:0090234;GO:0090230;GO:1902115;GO:0090169;GO:0090224,regulation of spindle organization,0.951785714
0,0.033097755,2,23,GO:0034599,cellular response to oxidative stress,0.954216867
0,0.0355025,3,23,GO:0009749;GO:0009746;GO:0034284;GO:0009743,response to carbohydrate,0.955084746
0,0.01179006,2,149,GO:0006457,protein folding,0.955263158
0,0.032962479,2,20,GO:0006885;GO:0055067,regulation of pH,0.956363636
0,0.048381061,2,22,GO:0006801,superoxide metabolic process,0.956623932
0,0.041282675,2,44,GO:0071103,DNA conformation change,0.957178218
0,0.032852474,2,28,GO:0048813,dendrite morphogenesis,0.957621951
0,0.041530523,3,32,GO:0043434;GO:1901652,response to peptide,0.957635468
0,0.014085658,2,40,GO:0007265,Ras protein signal transduction,0.957746479
0,0.049117037,3,115,GO:0006417;GO:0010608;GO:0034248,posttranscriptional regulation of gene expression,0.957805907
0,0.048663388,3,37,GO:0048588,developmental cell growth,0.95787234
0,0.052187675,2,130,GO:0009719,response to endogenous stimulus,0.958467742
0,0.049720092,3,61,GO:0071495,cellular response to endogenous stimulus,0.958995816
0,0.049339402,2,47,GO:0044242,cellular lipid catabolic process,0.95987395
0,0.048156916,7,18,GO:0006306;GO:0006305;GO:0044728;GO:0006304,DNA modification,0.959913793
0,0.052104665,4,56,GO:0007596;GO:0007599;GO:0050817,hemostasis,0.960323887
0,0.035499467,2,16,GO:1902850,microtubule cytoskeleton organization involved in mitosis,0.960511364
0,0.051864781,2,98,GO:0010243;GO:1901698,response to nitrogen compound,0.960569106
0,0.049064048,6,20,GO:0042593;GO:0033500,glucose homeostasis,0.96059322
0,0.048376654,2,60,GO:0051052,regulation of DNA metabolic process,0.960729614
0,0.04645444,4,17,GO:1902107,positive regulation of leukocyte differentiation,0.961383929
0,0.032819523,2,20,GO:0050727,regulation of inflammatory response,0.96196319
0,0.032819523,2,20,GO:0050728;GO:0031348;GO:0032720;GO:0032680;GO:1903556;GO:1903555,negative regulation of defense response,0.96196319
0,0.032819523,2,20,GO:0071219;GO:0071216,cellular response to biotic stimulus,0.96196319
0,0.010404859,2,111,GO:0000209,protein polyubiquitination,0.962244898
0,0.04394203,3,40,GO:0006275,regulation of DNA replication,0.96314554
0,0.048081803,4,51,GO:0002237,response to molecule of bacterial origin,0.963419913
0,0.035459981,3,49,GO:0001505,regulation of neurotransmitter levels,0.963428571
0,0.046123493,2,43,GO:0006874;GO:0055074;GO:0072503;GO:0072507,divalent inorganic cation homeostasis,0.963738739
0,0.050421345,4,15,GO:0034968;GO:0016571,histone methylation,0.963958333
0,0.041977001,2,218,GO:0051726,regulation of cell cycle,0.964215686
0,0.052734329,5,610,GO:0031325;GO:0009893;GO:0010604;GO:0051173,positive regulation of metabolic process,0.964257028
0,0.051811069,2,49,GO:0002252,immune effector process,0.964285714
0,0.04638071,2,1023,GO:0048523;GO:0048519,negative regulation of biological process,0.964573991
0,0.045393789,2,41,GO:0032102,negative regulation of response to external stimulus,0.964678899
0,0.014014244,2,7,GO:0030316,osteoclast differentiation,0.965
0,0.044677378,2,39,GO:0001818,negative regulation of cytokine production,0.965348837
0,0.044677378,2,39,GO:0071417;GO:1901699,cellular response to organonitrogen compound,0.965348837
0,0.04226316,5,222,GO:0070647,protein modification by small protein conjugation or removal,0.966097561
0,0.05334524,3,11,GO:0006097;GO:0046487,glyoxylate metabolic process,0.966334661
0,0.043886468,2,37,GO:0032496,response to lipopolysaccharide,0.966745283
0,0.030796854,2,18,GO:0032868,response to insulin,0.966993464
0,0.051736898,2,251,GO:0007017,microtubule-based process,0.967418033
0,0.045316991,5,10,GO:0040010;GO:0040009,positive regulation of growth rate,0.967511521
0,0.048077179,2,20,GO:0048705,skeletal system morphogenesis,0.967608696
0,0.042786645,2,15,GO:0071300;GO:0032526,response to retinoic acid,0.96763285
0,0.046103721,2,41,GO:0045926,negative regulation of growth,0.967647059
0,0.045941736,4,40,GO:0006446,regulation of translational initiation,0.968181818
0,0.054897301,2,23,GO:0030100,regulation of endocytosis,0.968359375
0,0.045672582,2,16,GO:0006367,transcription initiation from RNA polymerase II promoter,0.968493151
0,0.05427809,3,46,GO:0000075,cell cycle checkpoint,0.968700787
0,0.045163284,2,13,GO:0002698,negative regulation of immune effector process,0.968981481
0,0.053288101,2,61,GO:0001667,ameboidal-type cell migration,0.969
0,0.051267589,2,118,GO:0009790,embryo development,0.969628099
0,0.032396324,2,161,GO:0044419,interspecies interaction between organisms,0.97
0,0.047581429,4,14,GO:0045580;GO:0045619,regulation of lymphocyte differentiation,0.970264317
0,0.054161733,5,40,GO:0046942;GO:0015849,organic acid transport,0.970355731
0,0.043811928,2,442,GO:0007275,multicellular organism development,0.970379147
0,0.03112458,4,39,GO:0006643,membrane lipid metabolic process,0.970454545
0,0.051089637,2,28,GO:0008063;GO:0034142,toll-like receptor 4 signaling pathway,0.970746888
0,0.051666618,2,90,GO:0009725,response to hormone,0.970781893
0,0.042709255,6,74,GO:0048812;GO:0120039;GO:0048858;GO:0032990,cell part morphogenesis,0.971359223
0,0.054827801,2,9,GO:0043624,cellular protein complex disassembly,0.971372549
0,0.01175193,4,48,GO:0000165;GO:0023014,signal transduction by protein phosphorylation,0.971428571
0,0.047908591,2,8,GO:0001516;GO:0006693;GO:0046457;GO:0006636,prostaglandin metabolic process,0.971710526
0,0.048073911,2,46,GO:0043484;GO:0048024;GO:0050684,regulation of RNA splicing,0.971834061
0,0.047535303,2,154,GO:0002684,positive regulation of immune system process,0.972787611
0,0.047312247,2,75,GO:0050878,regulation of body fluid levels,0.973555556
0,0.03150615,2,15,GO:0007266,Rho protein signal transduction,0.973870968
0,0.054159239,2,17,GO:0043488;GO:0043487;GO:0061013,regulation of mRNA catabolic process,0.974206349
0,0.032339289,2,11,GO:0045453,bone resorption,0.974528302
0,0.043809071,3,11,GO:0009187,cyclic nucleotide metabolic process,0.975
0,0.010319687,3,5,GO:0001553,luteinization,0.976041667
0,0.010319687,2,5,GO:0010761,fibroblast migration,0.976041667
0,0.03182362,4,24,GO:0040014,regulation of multicellular organism growth,0.976602564
0,0.043688182,3,17,GO:0098813,nuclear chromosome segregation,0.976794258
0,0.032225427,4,81,GO:0030003;GO:0006873;GO:0055082,cellular chemical homeostasis,0.977848101
0,0.043520837,6,1209,GO:0006355;GO:1903506;GO:2001141;GO:0051252;GO:0019219,regulation of nucleobase-containing compound metabolic process,0.978125
0,0.032089416,2,25,GO:0048002;GO:0019882,antigen processing and presentation,0.980254777
0,0.011635346,4,28,GO:0006665,sphingolipid metabolic process,0.980909091
0,0.056144082,4,18,GO:0046637;GO:0046634;GO:0033962;GO:0046007;GO:0042130;GO:0050672;GO:0050868;GO:0032945;GO:1903038;GO:0022408;GO:0030889;GO:0030888;GO:0002635;GO:0002823;GO:0002820;GO:0045623;GO:0043371;GO:0045622;GO:0043370;GO:0046639;GO:2000515;GO:2000514;GO:0045581;GO:0046636;GO:0045620;GO:1902106,negative regulation of cell-cell adhesion,0.981128405
0,0.013237493,2,5,GO:0033523,histone H2B ubiquitination,0.9828125
0,0.011386867,2,828,GO:0006950,response to stress,0.983018868
0,0.05869959,2,66,GO:0016570;GO:0016569,covalent chromatin modification,0.984339623
0,0.058061336,3,36,GO:0006959,humoral immune response,0.986450382
0,0.058659473,2,19,GO:0018022;GO:0006479;GO:0008213,protein methylation,0.986931818
0,0.011533272,2,6,GO:0007431,salivary gland development,0.987037037
0,0.002608059,6,19,GO:0006309;GO:0000737;GO:0006308,DNA catabolic process,0.988461538
0,0.058527842,2,13,GO:0007623,circadian rhythm,0.989163498
0,0.011234638,3,8,GO:0046685,response to arsenic-containing substance,0.989423077
0,0.058055218,-1,9,GO:0045749,obsolete negative regulation of S phase of mitotic cell cycle,0.990229885
0,0.062689108,3,6,GO:0070593,dendrite self-avoidance,0.99057971
0,0.061494782,5,25,GO:0015991;GO:0015988;GO:0099131;GO:0099132;GO:0090662,ATP hydrolysis coupled transmembrane transport,0.990992647
0,0.010068449,5,247,GO:0006281;GO:0006974,cellular response to DNA damage stimulus,0.991304348
0,0.057080842,4,147,GO:0007411;GO:0097485,axon guidance,0.991666667
0,0.060451626,2,467,GO:0032268;GO:0051246,regulation of protein metabolic process,0.991821561
0,0.061264083,5,16,GO:0007298;GO:0007297,border follicle cell migration,0.992435424
0,0.061911588,4,96,GO:0051276,chromosome organization,0.992490842
0,0.062096543,3,91,GO:0033365;GO:0072594,protein localization to organelle,0.992518248
0,0.06319288,2,30,GO:0071229,cellular response to acid chemical,0.993140794
0,0.062592687,3,52,GO:0050863;GO:0051249;GO:1903037;GO:0022407,regulation of lymphocyte activation,0.993454545
0,0.058033303,2,19,GO:0002695;GO:0050866,negative regulation of cell activation,0.993653846
0,0.058033303,3,19,GO:0050869;GO:0050864;GO:0051250;GO:0070664;GO:0002634,regulation of B cell activation,0.993653846
0,0.009889576,3,213,GO:0002682,regulation of immune system process,0.994444444
0,0.060423415,2,16,GO:0032103,positive regulation of response to external stimulus,0.995522388
0,0.060423415,6,16,GO:0042102;GO:0050671;GO:0032946;GO:0070665,positive regulation of leukocyte proliferation,0.995522388
0,0.061263001,3,28,GO:0045639;GO:0045637;GO:1903708,positive regulation of hemopoiesis,0.995925926
0,0.012634064,2,47,GO:0002683,negative regulation of immune system process,0.996666667
0,0.013199229,3,65,GO:0000956;GO:0006402;GO:0006401,RNA catabolic process,0.996825397
0,0.065184851,4,84,GO:0009792,embryo development ending in birth or egg hatching,0.998404255
0,0.012488962,2,7,GO:0000289,nuclear-transcribed mRNA poly(A) tail shortening,0.999152542
0,0.817167869,7,41,GO:0000041,transition metal ion transport,1
0,0.17995954,3,6,GO:0000050;GO:0019627;GO:0071941,urea cycle,1
0,0.75018152,3,31,GO:0000096,sulfur amino acid metabolic process,1
0,0.139614121,3,90,GO:0000122,negative regulation of transcription by RNA polymerase II,1
0,0.131304204,5,31,GO:0000187,activation of MAPK activity,1
0,0.483008538,3,24,GO:0000236;GO:0098763,mitotic cell cycle phase,1
0,0.327791243,2,26,GO:0000302,response to reactive oxygen species,1
0,0.073299839,3,32,GO:0000902,cell morphogenesis,1
0,0.0760909,3,54,GO:0001101,response to acid chemical,1
0,0.419715233,2,34,GO:0001501,skeletal system development,1
0,0.125296864,2,41,GO:0001503,ossification,1
0,0.164735069,4,17,GO:0001508,action potential,1
0,0.570383612,2,72,GO:0001525,angiogenesis,1
0,0.271141093,2,68,GO:0001558,regulation of cell growth,1
0,0.707374981,3,55,GO:0001654;GO:0007423,sensory organ development,1
0,0.218785297,3,39,GO:0001666;GO:0036293;GO:0070482,response to oxygen levels,1
0,0.089668295,6,54,GO:0001701;GO:0043009,chordate embryonic development,1
0,0.441439384,3,25,GO:0001708,cell fate specification,1
0,0.176636772,3,10,GO:0001736;GO:0007164,establishment of tissue polarity,1
0,0.19290206,2,27,GO:0001816,cytokine production,1
0,0.077713989,3,84,GO:0001817,regulation of cytokine production,1
0,0.253871906,5,55,GO:0001819,positive regulation of cytokine production,1
0,0.224514143,2,51,GO:0001822,kidney development,1
0,0.078590102,5,19,GO:0001843;GO:0060606,neural tube closure,1
0,0.133163731,5,28,GO:0001894,tissue homeostasis,1
0,0.232611076,3,306,GO:0001932;GO:0042325;GO:0019220;GO:0051174;GO:0031399,regulation of protein modification process,1
0,0.420205218,4,53,GO:0001933;GO:0031400;GO:0042326;GO:0045936;GO:0010563,negative regulation of protein modification process,1
0,0.214457507,3,200,GO:0001934;GO:0031401;GO:0042327;GO:0045937;GO:0010562,positive regulation of protein modification process,1
0,0.485077413,3,18,GO:0002053;GO:0010464,regulation of mesenchymal cell proliferation,1
0,0.298778407,3,22,GO:0002119;GO:0002164,larval development,1
0,0.085303834,4,46,GO:0002224;GO:0002221;GO:0002758;GO:0002218,activation of innate immune response,1
0,0.282180113,3,108,GO:0002253;GO:0050778,positive regulation of immune response,1
0,0.002215701,2,12,GO:0002274,myeloid leukocyte activation,1
0,0.00083513,6,14,GO:0002637;GO:0051023,regulation of immunoglobulin production,1
0,0.075693515,4,60,GO:0002694;GO:0050865,regulation of cell activation,1
0,0.108574135,5,19,GO:0002699,positive regulation of immune effector process,1
0,0.079742723,2,12,GO:0002702,positive regulation of production of molecular mediator of immune response,1
0,0.211032298,3,71,GO:0002757;GO:0002764,immune response-activating signal transduction,1
0,0.066198523,4,24,GO:0002822;GO:0002819,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1
0,0.138968621,4,29,GO:0002831,regulation of response to biotic stimulus,1
0,0.694209145,3,86,GO:0003002,regionalization,1
0,0.156066763,2,151,GO:0003006,developmental process involved in reproduction,1
0,0.249745066,4,7,GO:0003143;GO:0001947,heart looping,1
0,0.772362581,2,234,GO:0005975,carbohydrate metabolic process,1
0,0.601839548,5,29,GO:0005977;GO:0006073;GO:0044042,cellular glucan metabolic process,1
0,0.076959225,4,10,GO:0006013,mannose metabolic process,1
0,0.104138968,2,101,GO:0006066,alcohol metabolic process,1
0,0.109244177,2,26,GO:0006081,cellular aldehyde metabolic process,1
0,0.870138209,3,208,GO:0006091;GO:0055114,generation of precursor metabolites and energy,1
0,0.837201246,3,47,GO:0006096;GO:0006757;GO:0009166;GO:0019359;GO:0042866;GO:0006165;GO:0046031;GO:0009132;GO:0046939;GO:0009179;GO:0009135;GO:0009185;GO:1901292;GO:0019363;GO:0006090,nucleoside phosphate catabolic process,1
0,0.114166382,5,46,GO:0006099;GO:0006101;GO:0072350,citrate metabolic process,1
0,0.060300808,3,13,GO:0006103,2-oxoglutarate metabolic process,1
0,0.000587285,2,8,GO:0006111;GO:0010677;GO:0045912,regulation of gluconeogenesis,1
0,0.726878784,2,51,GO:0006112;GO:0015980,energy derivation by oxidation of organic compounds,1
0,0.444927822,4,520,GO:0006259,DNA metabolic process,1
0,0.410489665,2,78,GO:0006260,DNA replication,1
0,0.357256195,2,15,GO:0006261,DNA-dependent DNA replication,1
0,0.255260415,2,181,GO:0006278;GO:0071897,DNA biosynthetic process,1
0,0.248693205,3,153,GO:0006325,chromatin organization,1
0,0.284451327,4,12,GO:0006333,chromatin assembly or disassembly,1
0,0.484354224,2,29,GO:0006334;GO:0065004,nucleosome assembly,1
0,0.180739211,4,47,GO:0006338,chromatin remodeling,1
0,0.168424752,2,28,GO:0006342;GO:0045814;GO:0097549;GO:0034401,chromatin organization involved in regulation of transcription,1
0,0.083204908,6,753,GO:0006351;GO:0097659;GO:0032774,RNA biosynthetic process,1
0,0.424704587,4,298,GO:0006357,regulation of transcription by RNA polymerase II,1
0,0.312265815,7,62,GO:0006366,transcription by RNA polymerase II,1
0,0.20802479,2,12,GO:0006378;GO:0043631,RNA polyadenylation,1
0,0.442463677,6,430,GO:0006396,RNA processing,1
0,0.098673862,2,357,GO:0006397;GO:0016071,mRNA metabolic process,1
0,0.937708232,2,83,GO:0006399,tRNA metabolic process,1
0,0.220420256,2,22,GO:0006406;GO:0006405,RNA export from nucleus,1
0,0.25063056,2,69,GO:0006412,translation,1
0,0.890660051,7,55,GO:0006418;GO:0043039;GO:0043038,amino acid activation,1
0,0.208621667,2,5,GO:0006424;GO:0006433,glutamyl-tRNA aminoacylation,1
0,0.132270844,2,6,GO:0006465,signal peptide processing,1
0,0.065597613,2,196,GO:0006468;GO:0016310,phosphorylation,1
0,0.450772371,5,19,GO:0006471,protein ADP-ribosylation,1
0,0.113208617,2,9,GO:0006506;GO:0006505;GO:0009247,GPI anchor metabolic process,1
0,0.412971517,2,574,GO:0006508,proteolysis,1
0,0.092984199,2,165,GO:0006511;GO:0019941;GO:0051603;GO:0043632,proteolysis involved in cellular protein catabolic process,1
0,0.208078321,4,130,GO:0006518,peptide metabolic process,1
0,0.968680116,2,205,GO:0006520,cellular amino acid metabolic process,1
0,0.17995954,8,6,GO:0006525,arginine metabolic process,1
0,0.359401161,2,22,GO:0006541,glutamine metabolic process,1
0,0.704946471,3,27,GO:0006555;GO:0009086;GO:0000097;GO:0009067,methionine metabolic process,1
0,0.099153175,2,5,GO:0006582,melanin metabolic process,1
0,0.288708622,3,24,GO:0006584;GO:0009712,catecholamine metabolic process,1
0,0.339347367,2,66,GO:0006605,protein targeting,1
0,0.107938751,3,40,GO:0006606;GO:0017038;GO:0034504;GO:0051170,protein import,1
0,0.254410289,2,7,GO:0006611,protein export from nucleus,1
0,0.090486509,5,6,GO:0006622;GO:0061462,protein targeting to lysosome,1
0,0.12662576,3,9,GO:0006623;GO:0072666;GO:0072665,protein localization to vacuole,1
0,0.440426625,2,402,GO:0006629,lipid metabolic process,1
0,0.713694516,3,109,GO:0006631,fatty acid metabolic process,1
0,0.555641477,5,43,GO:0006633,fatty acid biosynthetic process,1
0,0.566357264,3,79,GO:0006644,phospholipid metabolic process,1
0,0.663551526,3,27,GO:0006662;GO:0018904,glycerol ether metabolic process,1
0,0.185826307,2,18,GO:0006664;GO:1903509,liposaccharide metabolic process,1
0,0.240375713,3,18,GO:0006691;GO:0031408;GO:0031407,leukotriene metabolic process,1
0,0.109971525,2,35,GO:0006694,steroid biosynthetic process,1
0,0.633239771,2,26,GO:0006730,one-carbon metabolic process,1
0,0.922783027,2,105,GO:0006732,coenzyme metabolic process,1
0,0.731651922,2,197,GO:0006753;GO:0055086;GO:0009117,nucleobase-containing small molecule metabolic process,1
0,0.386536639,4,77,GO:0006754;GO:0009206;GO:0046034;GO:0009145;GO:0009201;GO:0009205;GO:0009142;GO:0009144;GO:0009199;GO:0009141,nucleoside triphosphate metabolic process,1
0,0.45517902,2,37,GO:0006766,vitamin metabolic process,1
0,0.384610695,3,25,GO:0006767,water-soluble vitamin metabolic process,1
0,0.946734255,3,92,GO:0006790,sulfur compound metabolic process,1
0,0.145584688,2,469,GO:0006796;GO:0006793,phosphorus metabolic process,1
0,0.601989906,3,234,GO:0006811,ion transport,1
0,0.400854148,2,158,GO:0006812,cation transport,1
0,0.337748554,8,9,GO:0006826,iron ion transport,1
0,0.130577811,4,20,GO:0006836,neurotransmitter transport,1
0,0.093829397,5,67,GO:0006869,lipid transport,1
0,0.119223602,5,71,GO:0006875;GO:0055065,metal ion homeostasis,1
0,0.445967017,7,13,GO:0006879,cellular iron ion homeostasis,1
0,0.207862211,2,242,GO:0006886,intracellular protein transport,1
0,0.364970625,4,35,GO:0006888,endoplasmic reticulum to Golgi vesicle-mediated transport,1
0,0.233445599,6,57,GO:0006892,post-Golgi vesicle-mediated transport,1
0,0.146244429,3,18,GO:0006895,Golgi to endosome transport,1
0,0.360536015,2,34,GO:0006898,receptor-mediated endocytosis,1
0,0.170768084,3,15,GO:0006904;GO:0140029,exocytic process,1
0,0.265538624,5,18,GO:0006909,phagocytosis,1
0,0.258648954,5,71,GO:0006913;GO:0051169,nucleocytoplasmic transport,1
0,0.142084734,3,37,GO:0006914;GO:0061919,autophagy,1
0,0.311797671,2,391,GO:0006915;GO:0012501;GO:0008219,cell death,1
0,0.25258559,2,530,GO:0006928,movement of cell or subcellular component,1
0,0.093664602,3,234,GO:0006952,defense response,1
0,0.128268755,2,90,GO:0006954,inflammatory response,1
0,0.099611514,3,84,GO:0006979,response to oxidative stress,1
0,0.001506233,2,17,GO:0006984,ER-nucleus signaling pathway,1
0,0.012933401,4,28,GO:0006986;GO:0035966,response to topologically incorrect protein,1
0,0.505911336,4,22,GO:0007009,plasma membrane organization,1
0,0.117064126,4,53,GO:0007015,actin filament organization,1
0,0.752499592,2,158,GO:0007018,microtubule-based movement,1
0,0.690946148,2,26,GO:0007043;GO:0045216,cell-cell junction organization,1
0,0.084817592,3,31,GO:0007044,cell-substrate junction assembly,1
0,0.287096854,2,173,GO:0007049,cell cycle,1
0,0.118882438,3,66,GO:0007050,cell cycle arrest,1
0,0.068849557,3,30,GO:0007088;GO:0051783,regulation of nuclear division,1
0,0.633433326,2,157,GO:0007154,cell communication,1
0,0.870007694,2,492,GO:0007155;GO:0022610,cell adhesion,1
0,0.461881762,2,77,GO:0007156;GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,1
0,0.107731834,2,111,GO:0007163,establishment or maintenance of cell polarity,1
0,0.200120431,4,605,GO:0007166,cell surface receptor signaling pathway,1
0,0.113829917,2,206,GO:0007167;GO:0007169,enzyme linked receptor protein signaling pathway,1
0,0.51381611,3,16,GO:0007185,transmembrane receptor protein tyrosine phosphatase signaling pathway,1
0,0.715880938,2,127,GO:0007186,G protein-coupled receptor signaling pathway,1
0,0.216384871,4,7,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,1
0,0.16198016,3,5,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,1
0,0.557625065,2,18,GO:0007204;GO:0051480,regulation of cytosolic calcium ion concentration,1
0,0.216384871,3,7,GO:0007212,dopamine receptor signaling pathway,1
0,0.16982022,3,5,GO:0007214,gamma-aminobutyric acid signaling pathway,1
0,0.387465962,2,15,GO:0007215,glutamate receptor signaling pathway,1
0,0.504948269,3,58,GO:0007218,neuropeptide signaling pathway,1
0,0.492123922,2,87,GO:0007219,Notch signaling pathway,1
0,0.092458143,2,39,GO:0007229,integrin-mediated signaling pathway,1
0,0.332460459,2,16,GO:0007249,I-kappaB kinase/NF-kappaB signaling,1
0,0.140461129,5,213,GO:0007264,small GTPase mediated signal transduction,1
0,0.556977411,2,104,GO:0007267;GO:0023052,signaling,1
0,0.302705177,3,58,GO:0007268;GO:0098916;GO:0099537;GO:0099536,chemical synaptic transmission,1
0,0.089094648,4,9,GO:0007269,neurotransmitter secretion,1
0,0.361688278,6,13,GO:0007274,neuromuscular synaptic transmission,1
0,0.336073996,3,98,GO:0007283;GO:0048232,spermatogenesis,1
0,0.075867682,5,65,GO:0007346,regulation of mitotic cell cycle,1
0,0.009840028,3,5,GO:0007362,terminal region determination,1
0,0.431292002,2,14,GO:0007369,gastrulation,1
0,0.009840028,3,5,GO:0007379,segment specification,1
0,0.496802185,2,131,GO:0007389,pattern specification process,1
0,0.226236293,2,14,GO:0007391,dorsal closure,1
0,0.635530024,3,84,GO:0007399,nervous system development,1
0,0.606414643,2,40,GO:0007417,central nervous system development,1
0,0.074101156,2,44,GO:0007420,brain development,1
0,0.096797442,2,45,GO:0007507,heart development,1
0,0.457205622,4,18,GO:0007528,neuromuscular junction development,1
0,0.185098269,2,9,GO:0007566,embryo implantation,1
0,0.068403471,2,30,GO:0007568,aging,1
0,0.239835256,2,13,GO:0007569,cell aging,1
0,0.096767977,4,10,GO:0007589,body fluid secretion,1
0,0.980730943,4,159,GO:0007600,sensory perception,1
0,0.92462395,6,78,GO:0007601;GO:0050953,sensory perception of light stimulus,1
0,0.242245246,2,6,GO:0007602,phototransduction,1
0,0.50567197,2,16,GO:0007608;GO:0007606,sensory perception of chemical stimulus,1
0,0.571093945,1,116,GO:0007610,behavior,1
0,0.581635846,2,28,GO:0007626,locomotory behavior,1
0,0.413895221,2,12,GO:0007631,feeding behavior,1
0,0.135387219,2,51,GO:0008038;GO:0008037,cell recognition,1
0,0.625186641,5,68,GO:0008064;GO:0030832;GO:0030833;GO:0032271,regulation of actin polymerization or depolymerization,1
0,0.238706901,2,9,GO:0008154;GO:0030041,actin polymerization or depolymerization,1
0,0.086533069,2,106,GO:0008202,steroid metabolic process,1
0,0.100848936,3,66,GO:0008203;GO:0016125;GO:1902652,sterol metabolic process,1
0,0.079071604,4,15,GO:0008210,estrogen metabolic process,1
0,0.58008747,1,129,GO:0008283,cell population proliferation,1
0,0.620334629,2,137,GO:0008284,positive regulation of cell population proliferation,1
0,0.38104928,2,138,GO:0008285,negative regulation of cell population proliferation,1
0,0.085648665,2,27,GO:0008340,determination of adult lifespan,1
0,0.325361105,2,11,GO:0008344,adult locomotory behavior,1
0,0.101623901,4,44,GO:0008360,regulation of cell shape,1
0,0.246675841,2,216,GO:0008380,RNA splicing,1
0,0.202024478,2,34,GO:0008543,fibroblast growth factor receptor signaling pathway,1
0,0.390204778,2,13,GO:0008589,regulation of smoothened signaling pathway,1
0,0.508059725,3,157,GO:0008610,lipid biosynthetic process,1
0,0.139056734,5,6,GO:0008615;GO:0008614;GO:0042819;GO:0042816,pyridoxine biosynthetic process,1
0,0.478950952,2,51,GO:0009064,glutamine family amino acid metabolic process,1
0,0.76965823,2,33,GO:0009066,aspartate family amino acid metabolic process,1
0,0.332523505,6,13,GO:0009084,glutamine family amino acid biosynthetic process,1
0,0.888859152,5,64,GO:0009108,coenzyme biosynthetic process,1
0,0.803282935,4,37,GO:0009116;GO:1901657,glycosyl compound metabolic process,1
0,0.479521283,2,143,GO:0009150;GO:0006163;GO:0009259;GO:0072521;GO:0019693,purine-containing compound metabolic process,1
0,0.634847899,3,121,GO:0009152;GO:0006164;GO:0009260;GO:1901293;GO:0009165;GO:0072522;GO:0046390,nucleoside phosphate biosynthetic process,1
0,0.522830277,3,16,GO:0009164;GO:0034656;GO:1901658,nucleobase-containing small molecule catabolic process,1
0,0.269947706,2,15,GO:0009306;GO:0002790,peptide secretion,1
0,0.223901428,2,74,GO:0009314,response to radiation,1
0,0.101569174,2,34,GO:0009408;GO:0009266,response to temperature stimulus,1
0,0.831908749,3,43,GO:0009416,response to light stimulus,1
0,0.626098575,2,22,GO:0009582;GO:0009581,detection of abiotic stimulus,1
0,0.368191316,2,10,GO:0009583,detection of light stimulus,1
0,0.601689691,2,204,GO:0009605,response to external stimulus,1
0,0.09811305,3,48,GO:0009611,response to wounding,1
0,0.525921573,2,17,GO:0009612,response to mechanical stimulus,1
0,0.295688825,2,49,GO:0009615,response to virus,1
0,0.24303541,2,177,GO:0009628,response to abiotic stimulus,1
0,0.389212433,2,363,GO:0009653,anatomical structure morphogenesis,1
0,0.120892861,2,31,GO:0009755,hormone-mediated signaling pathway,1
0,0.183587973,2,47,GO:0009791,post-embryonic development,1
0,0.710304002,2,36,GO:0009798,axis specification,1
0,0.314755334,3,24,GO:0009886,post-embryonic animal morphogenesis,1
0,0.181126387,3,119,GO:0009887,animal organ morphogenesis,1
0,0.642250336,3,142,GO:0009888,tissue development,1
0,0.181907496,2,7,GO:0009913,epidermal cell differentiation,1
0,0.382113162,4,12,GO:0009948,anterior/posterior axis specification,1
0,0.440769348,4,39,GO:0009952,anterior/posterior pattern specification,1
0,0.4672257,2,35,GO:0009953,dorsal/ventral pattern formation,1
0,0.214399025,4,805,GO:0009966;GO:0010646;GO:0023051;GO:0048583,regulation of response to stimulus,1
0,0.543581997,2,383,GO:0009967;GO:0010647;GO:0023056;GO:0048584,positive regulation of response to stimulus,1
0,0.117328869,2,214,GO:0009968;GO:0010648;GO:0023057;GO:0048585,negative regulation of response to stimulus,1
0,0.444896947,3,81,GO:0010035,response to inorganic substance,1
0,0.429852388,2,60,GO:0010038,response to metal ion,1
0,0.079281514,3,80,GO:0010564,regulation of cell cycle process,1
0,0.107426687,3,30,GO:0010631,epithelial cell migration,1
0,0.469825831,6,28,GO:0010638,positive regulation of organelle organization,1
0,0.573539037,3,58,GO:0010639,negative regulation of organelle organization,1
0,0.001049319,5,11,GO:0010675;GO:0043255;GO:0010906,regulation of cellular carbohydrate metabolic process,1
0,0.410124308,6,61,GO:0010769,regulation of cell morphogenesis involved in differentiation,1
0,0.334895082,3,18,GO:0010771;GO:0010977;GO:0031345,negative regulation of neuron projection development,1
0,0.431734344,3,99,GO:0010817,regulation of hormone levels,1
0,0.069424776,6,24,GO:0010827,regulation of glucose transmembrane transport,1
0,0.464739826,6,20,GO:0010959,regulation of metal ion transport,1
0,0.213007854,2,132,GO:0010975;GO:0045664;GO:0120035;GO:0031344,regulation of neuron differentiation,1
0,0.598015307,4,25,GO:0014013;GO:0045685,regulation of gliogenesis,1
0,0.558818042,2,22,GO:0014014;GO:0045686;GO:0048710,negative regulation of gliogenesis,1
0,0.193129791,2,28,GO:0014706;GO:0060537,muscle tissue development,1
0,0.892598974,5,120,GO:0015074,DNA integration,1
0,0.393306046,6,80,GO:0015672,monovalent inorganic cation transport,1
0,0.17552783,2,67,GO:0015711;GO:0006820,anion transport,1
0,0.347095953,4,12,GO:0015718,monocarboxylic acid transport,1
0,0.088414934,4,70,GO:0016032;GO:0044403,viral process,1
0,0.149928405,2,88,GO:0016042,lipid catabolic process,1
0,0.09663218,2,57,GO:0016049,cell growth,1
0,0.091643725,4,75,GO:0016050,vesicle organization,1
0,0.822662998,3,44,GO:0016052,carbohydrate catabolic process,1
0,0.646120918,3,161,GO:0016055;GO:1905114,Wnt signaling pathway,1
0,0.118273317,2,44,GO:0016197,endosomal transport,1
0,0.349618378,4,27,GO:0016199;GO:0016198,axon midline choice point recognition,1
0,0.073754031,3,17,GO:0016202;GO:0048634;GO:1901861,regulation of muscle organ development,1
0,0.284481934,2,20,GO:0016331,morphogenesis of embryonic epithelium,1
0,0.090296564,2,56,GO:0016458,gene silencing,1
0,0.203306347,3,198,GO:0016477,cell migration,1
0,0.140466797,2,43,GO:0016482,cytosolic transport,1
0,0.217956579,4,36,GO:0016485,protein processing,1
0,0.216214164,4,11,GO:0016486,peptide hormone processing,1
0,0.009434355,3,177,GO:0016567;GO:0032446,protein modification by small protein conjugation,1
0,0.245822788,4,6,GO:0016578,histone deubiquitination,1
0,0.881581505,2,51,GO:0016579;GO:0070646,protein modification by small protein removal,1
0,0.12534607,4,85,GO:0016999,antibiotic metabolic process,1
0,0.753223996,3,253,GO:0017144,drug metabolic process,1
0,0.154050442,2,168,GO:0018193,peptidyl-amino acid modification,1
0,0.072890651,4,77,GO:0018205,peptidyl-lysine modification,1
0,0.196389057,3,35,GO:0018958,phenol-containing compound metabolic process,1
0,0.070506839,3,47,GO:0019216,regulation of lipid metabolic process,1
0,0.093969033,2,36,GO:0019221,cytokine-mediated signaling pathway,1
0,0.226858193,5,7,GO:0019227;GO:0098870,action potential propagation,1
0,0.871900075,2,83,GO:0019318;GO:0005996,monosaccharide metabolic process,1
0,0.069021602,2,5,GO:0019374,galactolipid metabolic process,1
0,0.372989499,3,10,GO:0019509;GO:0071267;GO:0043102;GO:0071265,L-methionine biosynthetic process,1
0,0.688411863,2,268,GO:0019637,organophosphate metabolic process,1
0,0.185894532,3,162,GO:0019725,cellular homeostasis,1
0,0.214738698,3,13,GO:0019730;GO:0019731,antimicrobial humoral response,1
0,0.20265941,2,12,GO:0019748,secondary metabolic process,1
0,0.845721782,2,430,GO:0019752;GO:0043436;GO:0006082,organic acid metabolic process,1
0,0.563737727,5,29,GO:0019932,second-messenger-mediated signaling,1
0,0.369587671,2,14,GO:0019933;GO:0019935,cAMP-mediated signaling,1
0,0.18017266,3,5,GO:0021587,cerebellum morphogenesis,1
0,0.456190561,2,14,GO:0021884;GO:0021954,central nervous system neuron development,1
0,0.327932979,3,9,GO:0021891,olfactory bulb interneuron development,1
0,0.136171282,2,5,GO:0021983,pituitary gland development,1
0,0.636732488,2,50,GO:0022403;GO:0044848,biological phase,1
0,0.2608926,3,11,GO:0022405;GO:0022404,hair cycle process,1
0,0.125697084,2,35,GO:0022411,cellular component disassembly,1
0,0.232702094,2,119,GO:0022412,cellular process involved in reproduction in multicellular organism,1
0,0.18561147,1,335,GO:0022414,reproductive process,1
0,0.131807041,2,21,GO:0022602,ovulation cycle process,1
0,0.290583613,3,214,GO:0022603,regulation of anatomical structure morphogenesis,1
0,0.193605755,2,105,GO:0022604,regulation of cell morphogenesis,1
0,0.18800525,3,465,GO:0022607,cellular component assembly,1
0,0.386237391,3,22,GO:0022613;GO:0044085;GO:0042254,cellular component biogenesis,1
0,0.091081408,2,63,GO:0022618;GO:0071826,ribonucleoprotein complex subunit organization,1
0,0.680845574,2,98,GO:0022900,electron transport chain,1
0,0.321722773,2,28,GO:0022904,respiratory electron transport chain,1
0,0.179575833,3,26,GO:0023061,signal release,1
0,0.936291642,5,107,GO:0030001,metal ion transport,1
0,0.071710931,2,22,GO:0030011,maintenance of cell polarity,1
0,0.38342791,2,155,GO:0030029;GO:0030036,actin filament-based process,1
0,0.112143082,3,186,GO:0030030,cell projection organization,1
0,0.650649536,2,29,GO:0030097,hemopoiesis,1
0,0.100803889,3,26,GO:0030098,lymphocyte differentiation,1
0,0.819692415,2,64,GO:0030111,regulation of Wnt signaling pathway,1
0,0.122958775,4,10,GO:0030148,sphingolipid biosynthetic process,1
0,0.008201589,2,12,GO:0030149;GO:0046466,membrane lipid catabolic process,1
0,0.076135715,3,111,GO:0030155,regulation of cell adhesion,1
0,0.919901079,2,94,GO:0030162,regulation of proteolysis,1
0,0.008505154,2,93,GO:0030163,protein catabolic process,1
0,0.71144988,2,36,GO:0030177,positive regulation of Wnt signaling pathway,1
0,0.081802236,2,25,GO:0030308,negative regulation of cell growth,1
0,0.201039966,2,10,GO:0030323,respiratory tube development,1
0,0.303829591,2,18,GO:0030326;GO:0035108,limb morphogenesis,1
0,0.650649536,2,29,GO:0030510,regulation of BMP signaling pathway,1
0,0.382113162,2,12,GO:0030514,negative regulation of BMP signaling pathway,1
0,0.188965174,6,11,GO:0030516;GO:0061387,regulation of extent of cell growth,1
0,0.104720364,5,23,GO:0030518;GO:0043401,intracellular steroid hormone receptor signaling pathway,1
0,0.064644657,6,11,GO:0030521,androgen receptor signaling pathway,1
0,0.424060693,2,16,GO:0030534,adult behavior,1
0,0.115000847,4,62,GO:0030855,epithelial cell differentiation,1
0,0.083472802,2,16,GO:0031018,endocrine pancreas development,1
0,0.137531478,3,10,GO:0031023,microtubule organizing center organization,1
0,0.417031981,6,16,GO:0031110,regulation of microtubule polymerization or depolymerization,1
0,0.300366952,8,21,GO:0031124;GO:0031123,RNA 3'-end processing,1
0,0.250548278,2,7,GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,1
0,0.819660824,5,48,GO:0031175,neuron projection development,1
0,0.239213674,2,108,GO:0031329;GO:0009894,regulation of catabolic process,1
0,0.885576315,2,62,GO:0031331;GO:0009896,positive regulation of catabolic process,1
0,0.211660911,5,9,GO:0031365,N-terminal protein amino acid modification,1
0,0.81804564,3,43,GO:0031396;GO:1903320,regulation of protein modification by small protein conjugation or removal,1
0,0.684281689,2,27,GO:0031398;GO:1903322,positive regulation of protein modification by small protein conjugation or removal,1
0,0.089773137,2,20,GO:0031424,keratinization,1
0,0.185914337,2,7,GO:0031497,chromatin assembly,1
0,0.190445012,3,5,GO:0031503,protein-containing complex localization,1
0,0.071710931,2,22,GO:0031581,hemidesmosome assembly,1
0,0.882746189,2,52,GO:0031589,cell-substrate adhesion,1
0,0.209128145,3,5,GO:0032023;GO:0031638,trypsinogen activation,1
0,0.489414901,3,33,GO:0032088,negative regulation of NF-kappaB transcription factor activity,1
0,0.136593082,3,6,GO:0032092,positive regulation of protein binding,1
0,0.082126922,4,91,GO:0032101,regulation of response to external stimulus,1
0,0.013079144,2,6,GO:0032148,activation of protein kinase B activity,1
0,0.450054846,2,101,GO:0032269;GO:0051248,negative regulation of protein metabolic process,1
0,0.18635621,3,260,GO:0032270;GO:0051247,positive regulation of protein metabolic process,1
0,0.130906209,6,14,GO:0032364;GO:0033483,oxygen homeostasis,1
0,0.09943001,2,21,GO:0032386,regulation of intracellular transport,1
0,0.718013381,10,30,GO:0032436;GO:1901800;GO:2000060;GO:1903052;GO:1903364,positive regulation of ubiquitin-dependent protein catabolic process,1
0,0.14294682,1,1070,GO:0032501,multicellular organismal process,1
0,0.0882844,2,20,GO:0032507;GO:0051651,maintenance of location in cell,1
0,0.130724951,3,14,GO:0032606,type I interferon production,1
0,0.085469052,2,8,GO:0032608,interferon-beta production,1
0,0.258538488,5,8,GO:0032722;GO:0032642;GO:0043619;GO:0043618;GO:0043620;GO:0071347;GO:0002248;GO:0097709;GO:0051541;GO:0042789;GO:0009299;GO:0070101;GO:0001961;GO:0070099;GO:0060760;GO:0010870;GO:0010869;GO:0032909;GO:0071634;GO:0010573,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,1
0,0.084729643,2,20,GO:0032755;GO:0002460;GO:0002250;GO:0042088;GO:0045410;GO:0045408,positive regulation of interleukin-6 production,1
0,0.560353237,3,171,GO:0032787,monocarboxylic acid metabolic process,1
0,0.119320573,3,319,GO:0032879,regulation of localization,1
0,0.159348856,2,41,GO:0032886,regulation of microtubule-based process,1
0,0.480855729,2,113,GO:0032940;GO:0046903,secretion,1
0,0.086815466,4,17,GO:0032984,protein-containing complex disassembly,1
0,0.357289424,2,25,GO:0033013,tetrapyrrole metabolic process,1
0,0.075543919,5,143,GO:0033043,regulation of organelle organization,1
0,0.113603166,2,27,GO:0033044,regulation of chromosome organization,1
0,0.283120422,3,16,GO:0033209,tumor necrosis factor-mediated signaling pathway,1
0,0.382113162,3,12,GO:0033334,fin morphogenesis,1
0,0.000673557,3,476,GO:0033554;GO:0051716,cellular response to stimulus,1
0,0.011174134,6,11,GO:0033559;GO:0006692,unsaturated fatty acid metabolic process,1
0,0.223772294,4,39,GO:0034097,response to cytokine,1
0,0.229015911,2,50,GO:0034220,ion transmembrane transport,1
0,0.496448693,2,60,GO:0034329;GO:0034330,cell junction organization,1
0,0.452644418,4,13,GO:0034332,adherens junction organization,1
0,0.308322415,-1,8,GO:0034339,obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor,1
0,0.822662998,5,44,GO:0034404,nucleobase-containing small molecule biosynthetic process,1
0,0.14791215,3,11,GO:0034453,microtubule anchoring,1
0,0.129607022,2,178,GO:0034613;GO:0070727,cellular macromolecule localization,1
0,0.132456017,2,7,GO:0034614,cellular response to reactive oxygen species,1
0,0.356876339,3,191,GO:0034622,cellular protein-containing complex assembly,1
0,0.445093291,2,1305,GO:0034654;GO:0018130;GO:0019438;GO:1901362;GO:0034645;GO:0009059,organic cyclic compound biosynthetic process,1
0,0.07836487,3,159,GO:0034655;GO:0019439;GO:0044270;GO:0046700;GO:1901361,organic cyclic compound catabolic process,1
0,0.95324893,5,201,GO:0034660,ncRNA metabolic process,1
0,0.552280931,2,41,GO:0034728;GO:0071824,nucleosome organization,1
0,0.158467004,3,24,GO:0034754,cellular hormone metabolic process,1
0,0.112489066,3,36,GO:0034762,regulation of transmembrane transport,1
0,0.150805739,8,71,GO:0035023,regulation of Rho protein signal transduction,1
0,0.45309406,2,40,GO:0035107,appendage morphogenesis,1
0,0.147915156,2,8,GO:0035112,genitalia morphogenesis,1
0,0.175703346,-1,10,GO:0035121,obsolete tail morphogenesis,1
0,0.218311557,3,45,GO:0035148,tube formation,1
0,0.466842586,3,16,GO:0035162,embryonic hemopoiesis,1
0,0.798149802,2,55,GO:0035239,tube morphogenesis,1
0,0.503125012,2,75,GO:0035295;GO:0060429,tube development,1
0,0.069284414,2,494,GO:0035556,intracellular signal transduction,1
0,0.435629874,1,120,GO:0040007,growth,1
0,0.13697865,2,146,GO:0040008,regulation of growth,1
0,0.009840028,2,5,GO:0040015,negative regulation of multicellular organism growth,1
0,0.129797268,3,6,GO:0040020;GO:0051445,regulation of meiotic nuclear division,1
0,0.147133509,2,8,GO:0040024,dauer larval development,1
0,0.240363767,3,27,GO:0042058;GO:1901184,regulation of epidermal growth factor receptor signaling pathway,1
0,0.154610386,2,13,GO:0042059;GO:1901185,negative regulation of epidermal growth factor receptor signaling pathway,1
0,0.361688278,6,13,GO:0042062;GO:0048790;GO:0099558;GO:1990709;GO:0007026;GO:0031111;GO:0031114;GO:0030721,regulation of microtubule depolymerization,1
0,0.12133396,3,26,GO:0042108;GO:0042035,regulation of cytokine biosynthetic process,1
0,0.505840729,3,36,GO:0042110,T cell activation,1
0,0.008907748,4,25,GO:0042113,B cell activation,1
0,0.257824833,4,274,GO:0042127,regulation of cell population proliferation,1
0,0.325260867,2,21,GO:0042168;GO:0006778,porphyrin-containing compound metabolic process,1
0,0.475089904,2,67,GO:0042176,regulation of protein catabolic process,1
0,0.227306597,5,11,GO:0042364;GO:0009110,water-soluble vitamin biosynthetic process,1
0,0.561201289,3,47,GO:0042391,regulation of membrane potential,1
0,0.200371104,2,30,GO:0042440,pigment metabolic process,1
0,0.23718419,2,53,GO:0042445,hormone metabolic process,1
0,0.240687735,2,7,GO:0042474;GO:0042473,middle ear morphogenesis,1
0,0.109263607,2,24,GO:0042475;GO:0042476,odontogenesis,1
0,0.370531387,3,83,GO:0042493,response to drug,1
0,0.192079272,4,19,GO:0042552;GO:0008366;GO:0007272,axon ensheathment,1
0,0.225740431,2,272,GO:0042592,homeostatic process,1
0,0.211176267,2,6,GO:0042733,embryonic digit morphogenesis,1
0,0.376528862,4,48,GO:0042742;GO:0009617,response to bacterium,1
0,0.154068726,3,9,GO:0042773,ATP synthesis coupled electron transport,1
0,0.756840544,2,235,GO:0042981;GO:0043067;GO:0010941,regulation of cell death,1
0,0.287444272,2,23,GO:0043010,camera-type eye development,1
0,0.001425715,3,8,GO:0043011;GO:0001773;GO:0097028;GO:0019886;GO:0002495;GO:0002504;GO:0070498;GO:0045084;GO:0031666,myeloid dendritic cell activation,1
0,0.251488223,5,116,GO:0043043;GO:0043604,amide biosynthetic process,1
0,0.715897542,4,69,GO:0043065;GO:0043068;GO:0010942,positive regulation of cell death,1
0,0.106387065,2,234,GO:0043085;GO:0044093,positive regulation of molecular function,1
0,0.387266654,2,39,GO:0043086,negative regulation of catalytic activity,1
0,0.185563545,2,8,GO:0043087,regulation of GTPase activity,1
0,0.582663182,3,19,GO:0043094,cellular metabolic compound salvage,1
0,0.08261944,2,69,GO:0043123;GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,1
0,0.182199567,2,141,GO:0043207;GO:0009607,response to biotic stimulus,1
0,0.364097276,2,83,GO:0043254,regulation of protein complex assembly,1
0,0.580371495,3,31,GO:0043269,regulation of ion transport,1
0,0.16198016,3,5,GO:0043271,negative regulation of ion transport,1
0,0.147133509,2,8,GO:0043277,apoptotic cell clearance,1
0,0.139170701,3,5,GO:0043392,negative regulation of DNA binding,1
0,0.302665702,2,17,GO:0043393,regulation of protein binding,1
0,0.215962754,4,86,GO:0043406;GO:0043405;GO:0071902,regulation of MAP kinase activity,1
0,0.20265941,6,12,GO:0043407,negative regulation of MAP kinase activity,1
0,0.300365669,6,22,GO:0043409,negative regulation of MAPK cascade,1
0,0.287223467,2,141,GO:0043410;GO:0043408,regulation of MAPK cascade,1
0,0.412107612,2,52,GO:0043433,negative regulation of DNA-binding transcription factor activity,1
0,0.139170701,2,5,GO:0043486;GO:0043044,histone exchange,1
0,0.173851539,3,8,GO:0043496,regulation of protein homodimerization activity,1
0,0.330810251,3,49,GO:0043507;GO:0043506,regulation of JUN kinase activity,1
0,0.132456017,3,7,GO:0043508,negative regulation of JUN kinase activity,1
0,0.385752704,4,12,GO:0043542,endothelial cell migration,1
0,0.078797784,3,195,GO:0043603,cellular amide metabolic process,1
0,0.111301507,2,42,GO:0043648,dicarboxylic acid metabolic process,1
0,0.204595991,2,52,GO:0043900,regulation of multi-organism process,1
0,0.13770669,3,14,GO:0043954,cellular component maintenance,1
0,0.462422353,3,150,GO:0044087,regulation of cellular component biogenesis,1
0,0.447799903,2,99,GO:0044092,negative regulation of molecular function,1
0,0.625295404,2,254,GO:0044255,cellular lipid metabolic process,1
0,0.3412636,2,67,GO:0044262,cellular carbohydrate metabolic process,1
0,0.669581744,2,38,GO:0044264;GO:0005976,polysaccharide metabolic process,1
0,0.863252905,2,47,GO:0044272,sulfur compound biosynthetic process,1
0,0.936930031,2,798,GO:0044281,small molecule metabolic process,1
0,0.944532768,2,88,GO:0044282,small molecule catabolic process,1
0,0.717269866,2,203,GO:0044283,small molecule biosynthetic process,1
0,0.153571129,2,131,GO:0045087,innate immune response,1
0,0.105667985,6,63,GO:0045089;GO:0031349;GO:0045088,regulation of innate immune response,1
0,0.08107808,4,28,GO:0045104;GO:0045103,intermediate filament cytoskeleton organization,1
0,0.37285818,3,32,GO:0045165,cell fate commitment,1
0,0.250989823,3,51,GO:0045185;GO:0051235,maintenance of location,1
0,0.344622624,2,69,GO:0045454,cell redox homeostasis,1
0,0.399486839,3,15,GO:0045478,fusome organization,1
0,0.345170724,2,26,GO:0045494,photoreceptor cell maintenance,1
0,0.151170757,2,267,GO:0045595,regulation of cell differentiation,1
0,0.433551549,2,115,GO:0045596,negative regulation of cell differentiation,1
0,0.193187355,2,121,GO:0045597,positive regulation of cell differentiation,1
0,0.325729626,6,15,GO:0045603;GO:0045601;GO:0048708;GO:0048709;GO:0046427;GO:1904894;GO:0002052;GO:2000179;GO:2000648;GO:0007221;GO:0042246,regulation of endothelial cell differentiation,1
0,0.472605773,2,36,GO:0045665,negative regulation of neuron differentiation,1
0,0.516428001,2,46,GO:0045666;GO:0010976;GO:0031346,positive regulation of neuron differentiation,1
0,0.812423529,3,42,GO:0045732,positive regulation of protein catabolic process,1
0,0.098748656,2,139,GO:0045786,negative regulation of cell cycle,1
0,0.328259458,2,38,GO:0045787,positive regulation of cell cycle,1
0,0.113755985,4,179,GO:0045859;GO:0043549;GO:0051338,regulation of transferase activity,1
0,0.090738071,3,123,GO:0045860;GO:0033674;GO:0051347,positive regulation of transferase activity,1
0,0.889651486,2,64,GO:0045862,positive regulation of proteolysis,1
0,0.295517593,3,9,GO:0045879,negative regulation of smoothened signaling pathway,1
0,0.18017266,3,5,GO:0045880,positive regulation of smoothened signaling pathway,1
0,0.095654498,4,35,GO:0045927,positive regulation of growth,1
0,0.272094014,3,144,GO:0045944,positive regulation of transcription by RNA polymerase II,1
0,0.660485818,5,30,GO:0045995,regulation of embryonic development,1
0,0.456391263,6,112,GO:0046328;GO:0032872;GO:0070302;GO:0080135,regulation of cellular response to stress,1
0,0.226236293,3,14,GO:0046329;GO:0032873;GO:0070303,negative regulation of stress-activated protein kinase signaling cascade,1
0,0.431754371,4,62,GO:0046330;GO:0032874;GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,1
0,0.45603666,3,136,GO:0046394;GO:0016053,organic acid biosynthetic process,1
0,0.869846179,2,56,GO:0046434,organophosphate catabolic process,1
0,0.011174134,3,11,GO:0046456,icosanoid biosynthetic process,1
0,0.179256849,2,17,GO:0046467,membrane lipid biosynthetic process,1
0,0.649645868,6,55,GO:0046496;GO:0019362;GO:0006733;GO:0072524,pyridine-containing compound metabolic process,1
0,0.316349647,4,139,GO:0046578;GO:0051056,regulation of small GTPase mediated signal transduction,1
0,0.176495096,3,7,GO:0046651;GO:0032943;GO:0070661,mononuclear cell proliferation,1
0,0.162630154,5,9,GO:0046686,response to cadmium ion,1
0,0.199042408,2,6,GO:0046717,acid secretion,1
0,0.087439657,3,61,GO:0046777,protein autophosphorylation,1
0,0.284451327,3,12,GO:0046782;GO:0050434;GO:0048524,positive regulation of viral process,1
0,0.181313206,4,10,GO:0046822,regulation of nucleocytoplasmic transport,1
0,0.132456017,3,7,GO:0046843,dorsal appendage formation,1
0,0.573052635,2,19,GO:0046916,cellular transition metal ion homeostasis,1
0,0.440769348,2,39,GO:0048011;GO:0038179,neurotrophin TRK receptor signaling pathway,1
0,0.204023906,7,9,GO:0048013,ephrin receptor signaling pathway,1
0,0.218767294,3,6,GO:0048096;GO:0045815,chromatin-mediated maintenance of transcription,1
0,0.087563093,2,110,GO:0048193,Golgi vesicle transport,1
0,0.306638229,2,9,GO:0048264;GO:0035143;GO:0035141,determination of ventral identity,1
0,0.070944984,3,32,GO:0048278;GO:0140056;GO:0022406,membrane docking,1
0,0.653566668,2,144,GO:0048468,cell development,1
0,0.458479115,2,27,GO:0048469;GO:0021700,developmental maturation,1
0,0.729269972,3,328,GO:0048513,animal organ development,1
0,0.167455266,4,1073,GO:0048522;GO:0048518,positive regulation of biological process,1
0,0.591533303,2,46,GO:0048534,hematopoietic or lymphoid organ development,1
0,0.226858193,3,7,GO:0048536,spleen development,1
0,0.325361105,2,11,GO:0048538,thymus development,1
0,0.61709305,4,28,GO:0048562,embryonic organ morphogenesis,1
0,0.189969053,2,11,GO:0048563,post-embryonic animal organ morphogenesis,1
0,0.150755434,2,7,GO:0048565,digestive tract development,1
0,0.419827122,2,37,GO:0048568,embryonic organ development,1
0,0.233423788,2,83,GO:0048589,developmental growth,1
0,0.516936216,2,20,GO:0048592;GO:0090596,sensory organ morphogenesis,1
0,0.778433517,2,120,GO:0048598,embryonic morphogenesis,1
0,0.190135827,2,140,GO:0048609;GO:0007276,multicellular organismal reproductive process,1
0,0.072107588,2,53,GO:0048638,regulation of developmental growth,1
0,0.471299864,2,246,GO:0048646,anatomical structure formation involved in morphogenesis,1
0,0.387465962,5,15,GO:0048660,regulation of smooth muscle cell proliferation,1
0,0.189853252,3,6,GO:0048661,positive regulation of smooth muscle cell proliferation,1
0,0.278320808,2,12,GO:0048663,neuron fate commitment,1
0,0.743596726,3,34,GO:0048666,neuron development,1
0,0.123687073,4,22,GO:0048675;GO:1990138,neuron projection extension,1
0,0.18017266,2,5,GO:0048701,embryonic cranial skeleton morphogenesis,1
0,0.320969219,5,10,GO:0048704,embryonic skeletal system morphogenesis,1
0,0.201039966,5,10,GO:0048706,embryonic skeletal system development,1
0,0.184470426,4,5,GO:0048712,negative regulation of astrocyte differentiation,1
0,0.709557331,2,97,GO:0048729;GO:0002009,tissue morphogenesis,1
0,0.812250189,2,211,GO:0048731,system development,1
0,0.108334003,2,40,GO:0048732,gland development,1
0,0.366612855,4,18,GO:0048762;GO:0001837,mesenchymal cell differentiation,1
0,0.099153175,5,5,GO:0048803;GO:0048805;GO:0048808;GO:0035126;GO:0090598,imaginal disc-derived genitalia morphogenesis,1
0,0.432914253,4,29,GO:0048814;GO:0050773,regulation of dendrite development,1
0,0.238231334,2,14,GO:0048854,brain morphogenesis,1
0,0.350735962,2,1084,GO:0048856,anatomical structure development,1
0,0.134157693,2,269,GO:0048870;GO:0040011,locomotion,1
0,0.072459171,3,145,GO:0048878,chemical homeostasis,1
0,0.74285633,2,47,GO:0050678,regulation of epithelial cell proliferation,1
0,0.636532438,3,30,GO:0050679,positive regulation of epithelial cell proliferation,1
0,0.516936216,4,20,GO:0050680,negative regulation of epithelial cell proliferation,1
0,0.178036364,3,53,GO:0050708;GO:0002791,regulation of peptide secretion,1
0,0.165202032,5,8,GO:0050766;GO:0050764,regulation of phagocytosis,1
0,0.396117788,2,173,GO:0050767;GO:0060284;GO:0051960,regulation of nervous system development,1
0,0.683779637,6,70,GO:0050768;GO:0010721;GO:0051961,negative regulation of nervous system development,1
0,0.557561755,2,70,GO:0050769;GO:0010720;GO:0051962,positive regulation of nervous system development,1
0,0.381894758,3,38,GO:0050770,regulation of axonogenesis,1
0,0.157597902,3,266,GO:0050790,regulation of catalytic activity,1
0,0.065175477,2,472,GO:0050793,regulation of developmental process,1
0,0.71541703,3,56,GO:0050804;GO:0099177,modulation of chemical synaptic transmission,1
0,0.492864964,2,21,GO:0050806,positive regulation of synaptic transmission,1
0,0.507075107,3,45,GO:0050807,regulation of synapse organization,1
0,0.266016907,2,38,GO:0050808,synapse organization,1
0,0.180946652,2,46,GO:0050821;GO:0031647,regulation of protein stability,1
0,0.581635846,5,28,GO:0050852;GO:0050851;GO:0002429;GO:0002768,immune response-activating cell surface receptor signaling pathway,1
0,0.218311557,2,45,GO:0050870;GO:0051251;GO:1903039;GO:0002696;GO:0050867;GO:0022409;GO:0045785,positive regulation of cell adhesion,1
0,0.994274697,2,290,GO:0050877;GO:0003008,system process,1
0,0.80122986,4,44,GO:0050890;GO:0007611,cognition,1
0,0.536268135,3,83,GO:0051028;GO:0050658;GO:0050657;GO:0051236;GO:0015931,nucleic acid transport,1
0,0.292038595,2,84,GO:0051046;GO:1903530,regulation of secretion,1
0,0.072833901,2,186,GO:0051049,regulation of transport,1
0,0.480089329,4,60,GO:0051050,positive regulation of transport,1
0,0.643152441,4,118,GO:0051090,regulation of DNA-binding transcription factor activity,1
0,0.113369526,2,167,GO:0051093,negative regulation of developmental process,1
0,0.196371782,2,177,GO:0051094,positive regulation of developmental process,1
0,0.304735979,3,34,GO:0051098,regulation of binding,1
0,0.265906001,2,14,GO:0051099,positive regulation of binding,1
0,0.247926135,2,10,GO:0051100,negative regulation of binding,1
0,0.347525305,2,16,GO:0051101,regulation of DNA binding,1
0,0.117629299,2,412,GO:0051128,regulation of cellular component organization,1
0,0.323516303,2,104,GO:0051129,negative regulation of cellular component organization,1
0,0.599776829,5,90,GO:0051130,positive regulation of cellular component organization,1
0,0.366454374,2,33,GO:0051168,nuclear export,1
0,0.579232293,3,206,GO:0051186,cofactor metabolic process,1
0,0.43400189,3,40,GO:0051187,cofactor catabolic process,1
0,0.831512193,2,102,GO:0051188,cofactor biosynthetic process,1
0,0.183139035,2,239,GO:0051240,positive regulation of multicellular organismal process,1
0,0.101468507,2,14,GO:0051258,protein polymerization,1
0,0.664733416,3,86,GO:0051259,protein complex oligomerization,1
0,0.597859149,4,47,GO:0051260,protein homooligomerization,1
0,0.650939554,2,23,GO:0051262,protein tetramerization,1
0,0.478543669,2,14,GO:0051289,protein homotetramerization,1
0,0.291718513,4,17,GO:0051291,protein heterooligomerization,1
0,0.488791891,2,202,GO:0051301,cell division,1
0,0.553122244,4,73,GO:0051336,regulation of hydrolase activity,1
0,0.144889864,2,103,GO:0051493,regulation of cytoskeleton organization,1
0,0.393571095,7,20,GO:0051495;GO:1902905,positive regulation of cytoskeleton organization,1
0,0.144394525,2,52,GO:0051604,protein maturation,1
0,0.372442271,2,51,GO:0051606,detection of stimulus,1
0,0.143067654,4,16,GO:0051607,defense response to virus,1
0,0.367039699,2,91,GO:0051640,organelle localization,1
0,0.106762017,2,527,GO:0051641;GO:0046907;GO:0051649,cellular localization,1
0,0.274582638,3,50,GO:0051656,establishment of organelle localization,1
0,0.518449031,2,50,GO:0051693;GO:0030835;GO:0030837;GO:0030834;GO:0051494;GO:1901880;GO:1902904;GO:1901879;GO:0043242;GO:0043244;GO:0032272;GO:0031333,negative regulation of cytoskeleton organization,1
0,0.090501,1,289,GO:0051704,multi-organism process,1
0,0.348296024,2,100,GO:0051707,response to other organism,1
0,0.623796189,4,22,GO:0055072,iron ion homeostasis,1
0,0.737807897,3,31,GO:0055076,transition metal ion homeostasis,1
0,0.08971598,2,101,GO:0055080;GO:0098771;GO:0050801,ion homeostasis,1
0,0.317940035,3,156,GO:0055085,transmembrane transport,1
0,0.214171007,4,44,GO:0060249,anatomical structure homeostasis,1
0,0.2413055,4,11,GO:0060271;GO:0044782,cilium organization,1
0,0.087633182,2,16,GO:0060325,face morphogenesis,1
0,0.199194882,2,37,GO:0060341,regulation of cellular localization,1
0,0.244301944,3,42,GO:0060560,developmental growth involved in morphogenesis,1
0,0.520268238,2,19,GO:0060562,epithelial tube morphogenesis,1
0,0.116116205,3,51,GO:0060627,regulation of vesicle-mediated transport,1
0,0.199935836,2,5,GO:0060763,mammary duct terminal end bud growth,1
0,0.718419855,3,37,GO:0060828,regulation of canonical Wnt signaling pathway,1
0,0.297548895,2,15,GO:0061001;GO:0060998;GO:0099175,regulation of dendritic spine development,1
0,0.204023906,5,9,GO:0061002;GO:0050774;GO:0061000;GO:2000171,negative regulation of dendritic spine morphogenesis,1
0,0.2368556,2,111,GO:0061024,membrane organization,1
0,0.828488667,3,45,GO:0061136;GO:1903050;GO:1903362;GO:0032434;GO:2000058,regulation of cellular protein catabolic process,1
0,0.480051495,2,320,GO:0065003;GO:0043933,protein-containing complex subunit organization,1
0,0.251761822,2,764,GO:0065008,regulation of biological quality,1
0,0.425547328,2,396,GO:0065009,regulation of molecular function,1
0,0.186952746,2,5,GO:0070121,Kupffer's vesicle development,1
0,0.064312627,3,26,GO:0070507,regulation of microtubule cytoskeleton organization,1
0,0.190507343,2,77,GO:0070925,organelle assembly,1
0,0.183318859,3,26,GO:0070936,protein K48-linked ubiquitination,1
0,0.068963065,3,12,GO:0070979,protein K11-linked ubiquitination,1
0,0.257511927,2,17,GO:0071248;GO:0071241,cellular response to inorganic substance,1
0,0.378949199,2,19,GO:0071695,anatomical structure maturation,1
0,0.240247745,3,878,GO:0071702;GO:0071705;GO:0015031;GO:0015833;GO:0045184;GO:0042886;GO:0008104;GO:0033036,organic substance transport,1
0,0.249028714,2,112,GO:0071900,regulation of protein serine/threonine kinase activity,1
0,0.333841755,3,27,GO:0071901;GO:0006469;GO:0033673;GO:0051348,negative regulation of kinase activity,1
0,0.402504437,2,73,GO:0072330,monocarboxylic acid biosynthetic process,1
0,0.167005488,2,5,GO:0072499,photoreceptor cell axon guidance,1
0,0.45303671,2,36,GO:0072525,pyridine-containing compound biosynthetic process,1
0,0.45634928,3,62,GO:0072593,reactive oxygen species metabolic process,1
0,0.284258593,5,9,GO:0072595,maintenance of protein localization in organelle,1
0,0.087122251,4,204,GO:0080134,regulation of response to stress,1
0,0.301284039,2,120,GO:0090066;GO:0032535,regulation of anatomical structure size,1
0,0.425745303,2,23,GO:0090068,positive regulation of cell cycle process,1
0,0.774848748,2,48,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1
0,0.640314905,3,28,GO:0090101;GO:0090288,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1
0,0.486320548,4,17,GO:0090263,positive regulation of canonical Wnt signaling pathway,1
0,0.821767034,4,66,GO:0090287,regulation of cellular response to growth factor stimulus,1
0,0.729715296,2,170,GO:0090407,organophosphate biosynthetic process,1
0,0.188528738,2,82,GO:0097435,supramolecular fiber organization,1
0,0.207609482,2,57,GO:0098542,defense response to other organism,1
0,0.471776914,2,94,GO:0098609,cell-cell adhesion,1
0,0.146244429,2,18,GO:0099643,signal release from synapse,1
0,0.096706708,3,44,GO:0120031;GO:0030031,plasma membrane bounded cell projection assembly,1
0,0.399538607,2,98,GO:0120036,plasma membrane bounded cell projection organization,1
0,0.701548588,2,229,GO:1901135,carbohydrate derivative metabolic process,1
0,0.830872422,2,41,GO:1901136,carbohydrate derivative catabolic process,1
0,0.480167935,4,126,GO:1901137,carbohydrate derivative biosynthetic process,1
0,0.71987801,2,330,GO:1901566,organonitrogen compound biosynthetic process,1
0,0.171784455,2,33,GO:1901568;GO:0006690,fatty acid derivative metabolic process,1
0,0.864949733,4,127,GO:1901605,alpha-amino acid metabolic process,1
0,0.690545877,2,53,GO:1901607;GO:0008652,cellular amino acid biosynthetic process,1
0,0.283805854,2,146,GO:1901615,organic hydroxy compound metabolic process,1
0,0.10971528,2,32,GO:1901617,organic hydroxy compound biosynthetic process,1
0,0.00946621,2,25,GO:1902105,regulation of leukocyte differentiation,1
0,0.185217804,2,363,GO:1902531,regulation of intracellular signal transduction,1
0,0.412990737,3,49,GO:1902532,negative regulation of intracellular signal transduction,1
0,0.203004997,3,184,GO:1902533,positive regulation of intracellular signal transduction,1
0,0.166406795,6,41,GO:1902600;GO:0098662;GO:0098655;GO:0098660,cation transmembrane transport,1
0,0.271530909,2,89,GO:1902903;GO:0110053;GO:0032956;GO:0032970,regulation of actin cytoskeleton organization,1
0,0.119761685,2,37,GO:1903046,meiotic cell cycle process,1
0,0.064884934,3,136,GO:1903047,mitotic cell cycle process,1
0,0.089029593,2,55,GO:1903311,regulation of mRNA metabolic process,1
0,0.068940202,2,26,GO:1903707,negative regulation of hemopoiesis,1
0,0.566337757,5,22,GO:1905330,regulation of morphogenesis of an epithelium,1
0,0.297548895,3,15,GO:1905809,negative regulation of synapse organization,1
0,0.140423335,3,346,GO:2000026,regulation of multicellular organismal development,1
0,0.77081079,2,47,GO:2000027,regulation of animal organ morphogenesis,1
0,0.252676577,2,14,GO:2000241,regulation of reproductive process,1
0,0.447201839,3,15,GO:2000826,regulation of heart morphogenesis,1
0,1,1,16,GO:0000003,reproduction,1
0,1,3,8,GO:0000018,regulation of DNA recombination,1
0,1,3,7,GO:0000045;GO:1905037,autophagosome organization,1
0,1,5,6,GO:0000070,mitotic sister chromatid segregation,1
0,1,6,25,GO:0000077;GO:0031570,DNA integrity checkpoint,1
0,1,7,25,GO:0000079;GO:1904029,regulation of cyclin-dependent protein serine/threonine kinase activity,1
0,1,3,20,GO:0000082;GO:0044843,G1/S transition of mitotic cell cycle,1
0,1,4,35,GO:0000086;GO:0044839,cell cycle G2/M phase transition,1
0,1,3,10,GO:0000089;GO:0051323,metaphase,1
0,1,2,13,GO:0000186,activation of MAPKK activity,1
0,1,2,16,GO:0000216;GO:0000084;GO:0051320,S phase,1
0,1,3,8,GO:0000245,spliceosomal complex assembly,1
0,1,2,11,GO:0000272,polysaccharide catabolic process,1
0,1,3,8,GO:0000278,mitotic cell cycle,1
0,1,3,5,GO:0000387,spliceosomal snRNP assembly,1
0,1,5,6,GO:0000389,mRNA 3'-splice site recognition,1
0,1,3,5,GO:0000460,maturation of 5.8S rRNA,1
0,1,5,15,GO:0000723;GO:0032200,telomere organization,1
0,1,6,12,GO:0000724;GO:0000725,recombinational repair,1
0,1,4,8,GO:0000731,DNA synthesis involved in DNA repair,1
0,1,2,12,GO:0000819,sister chromatid segregation,1
0,1,2,23,GO:0000904,cell morphogenesis involved in differentiation,1
0,1,2,9,GO:0001502,cartilage condensation,1
0,1,2,5,GO:0001510,RNA methylation,1
0,1,7,7,GO:0001522,pseudouridine synthesis,1
0,1,4,8,GO:0001523;GO:0016101;GO:0006721,diterpenoid metabolic process,1
0,1,3,18,GO:0001539,cilium or flagellum-dependent cell motility,1
0,1,3,6,GO:0001541,ovarian follicle development,1
0,1,3,5,GO:0001542;GO:0030728,ovulation from ovarian follicle,1
0,1,2,5,GO:0001550,ovarian cumulus expansion,1
0,1,2,17,GO:0001568,blood vessel development,1
0,1,4,20,GO:0001570,vasculogenesis,1
0,1,2,5,GO:0001649,osteoblast differentiation,1
0,1,3,19,GO:0001656,metanephros development,1
0,1,4,24,GO:0001657;GO:0072164;GO:0072163,mesonephric tubule development,1
0,1,3,6,GO:0001658,branching involved in ureteric bud morphogenesis,1
0,1,5,6,GO:0001678,cellular glucose homeostasis,1
0,1,3,40,GO:0001704,formation of primary germ layer,1
0,1,2,27,GO:0001707,mesoderm formation,1
0,1,3,20,GO:0001709,cell fate determination,1
0,1,7,15,GO:0001751;GO:0045314;GO:0042478;GO:0110116;GO:0007474;GO:0045610;GO:0009608;GO:0042676;GO:0046667;GO:0046666;GO:0007451;GO:0035161;GO:0035165;GO:0035163;GO:0042688;GO:0042386;GO:0035153;GO:0035214;GO:0030708;GO:0048139;GO:0048138;GO:0007403;GO:0035172;GO:0007446;GO:0008587;GO:0035171;GO:0035168;GO:0042387;GO:0007478;GO:0007560;GO:0035111;GO:0035170;GO:0007521;GO:0045316;GO:0042480;GO:0110118;GO:0035157;GO:0009996;GO:0035155;GO:0007314;GO:0007309;GO:0030720;GO:0051674;GO:0030713;GO:0045750;GO:0048052;GO:0007464;GO:0001752;GO:0042706;GO:0046552;GO:0045466;GO:0045463;GO:0007460;GO:0042686;GO:0051890;GO:2000043;GO:1905207;GO:0042689;GO:0045468;GO:0016330;GO:0007419;GO:0007473;GO:0007449,compound eye photoreceptor fate commitment,1
0,1,6,11,GO:0001754;GO:0046530,eye photoreceptor cell differentiation,1
0,1,3,16,GO:0001755,neural crest cell migration,1
0,1,4,23,GO:0001764,neuron migration,1
0,1,5,9,GO:0001778,plasma membrane repair,1
0,1,6,9,GO:0001841,neural tube formation,1
0,1,2,7,GO:0001885,endothelial cell development,1
0,1,2,11,GO:0001889,liver development,1
0,1,7,11,GO:0001922;GO:0001782;GO:0045779;GO:0046851;GO:0034104;GO:2000349;GO:2000348;GO:2000352;GO:1904036;GO:2000351;GO:1904035;GO:0032703;GO:0090291;GO:0090289;GO:0034136;GO:0034122;GO:0034135;GO:0034121;GO:0034140;GO:0034139;GO:0070423;GO:0002753;GO:0035872;GO:0061043;GO:0072573;GO:0002507;GO:0031665;GO:0002832,cytoplasmic pattern recognition receptor signaling pathway,1
0,1,4,15,GO:0001938;GO:0001936,regulation of endothelial cell proliferation,1
0,1,2,7,GO:0001942,hair follicle development,1
0,1,4,11,GO:0001944,vasculature development,1
0,1,4,6,GO:0001958;GO:0036075,endochondral ossification,1
0,1,4,9,GO:0001959;GO:0060759,regulation of response to cytokine stimulus,1
0,1,2,5,GO:0001967,suckling behavior,1
0,1,3,6,GO:0001974,blood vessel remodeling,1
0,1,2,14,GO:0002011,morphogenesis of an epithelial sheet,1
0,1,7,10,GO:0002028,regulation of sodium ion transport,1
0,1,4,10,GO:0002062,chondrocyte differentiation,1
0,1,4,17,GO:0002064,epithelial cell development,1
0,1,2,11,GO:0002065,columnar/cuboidal epithelial cell differentiation,1
0,1,2,8,GO:0002066,columnar/cuboidal epithelial cell development,1
0,1,2,7,GO:0002067,glandular epithelial cell differentiation,1
0,1,5,9,GO:0002260;GO:0001776,lymphocyte homeostasis,1
0,1,2,5,GO:0002335,mature B cell differentiation,1
0,1,3,6,GO:0002366;GO:0002263;GO:0002285,leukocyte activation involved in immune response,1
0,1,4,18,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,1
0,1,2,5,GO:0002551;GO:0097531,mast cell chemotaxis,1
0,1,2,17,GO:0002576,platelet degranulation,1
0,1,2,7,GO:0002685,regulation of leukocyte migration,1
0,1,5,14,GO:0002703,regulation of leukocyte mediated immunity,1
0,1,2,12,GO:0002708;GO:0002705;GO:0002706,positive regulation of leukocyte mediated immunity,1
0,1,3,10,GO:0002709;GO:0002824;GO:0002821,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1
0,1,3,5,GO:0002726;GO:0002711;GO:0002720;GO:0002724;GO:0002718,positive regulation of T cell mediated immunity,1
0,1,2,6,GO:0002920,regulation of humoral immune response,1
0,1,2,8,GO:0003007,heart morphogenesis,1
0,1,2,28,GO:0003013,circulatory system process,1
0,1,2,6,GO:0003084;GO:0045777,positive regulation of blood pressure,1
0,1,4,5,GO:0003148,outflow tract septum morphogenesis,1
0,1,3,15,GO:0003156,regulation of animal organ formation,1
0,1,6,12,GO:0003264;GO:2000136,regulation of cell proliferation involved in heart morphogenesis,1
0,1,2,5,GO:0003407,neural retina development,1
0,1,4,10,GO:0005513,detection of calcium ion,1
0,1,5,9,GO:0005978;GO:0009250,glucan biosynthetic process,1
0,1,2,8,GO:0005980;GO:0009251;GO:0044247;GO:0044275,cellular carbohydrate catabolic process,1
0,1,2,6,GO:0006002,fructose 6-phosphate metabolic process,1
0,1,4,17,GO:0006004,fucose metabolic process,1
0,1,2,40,GO:0006006,glucose metabolic process,1
0,1,5,5,GO:0006012,galactose metabolic process,1
0,1,3,6,GO:0006020,inositol metabolic process,1
0,1,2,26,GO:0006022,aminoglycan metabolic process,1
0,1,3,8,GO:0006024;GO:0006023,aminoglycan biosynthetic process,1
0,1,2,6,GO:0006026,aminoglycan catabolic process,1
0,1,4,5,GO:0006029,proteoglycan metabolic process,1
0,1,3,11,GO:0006030;GO:1901071,glucosamine-containing compound metabolic process,1
0,1,3,15,GO:0006040,amino sugar metabolic process,1
0,1,4,8,GO:0006071;GO:0019400,glycerol metabolic process,1
0,1,3,23,GO:0006094;GO:0019319;GO:0046364,monosaccharide biosynthetic process,1
0,1,4,8,GO:0006105,succinate metabolic process,1
0,1,5,11,GO:0006140;GO:1900542,regulation of nucleotide metabolic process,1
0,1,2,15,GO:0006144,purine nucleobase metabolic process,1
0,1,2,8,GO:0006189;GO:0006188;GO:0046040,IMP biosynthetic process,1
0,1,-1,6,GO:0006200,obsolete ATP catabolic process,1
0,1,2,12,GO:0006206,pyrimidine nucleobase metabolic process,1
0,1,6,7,GO:0006207;GO:0019856,'de novo' pyrimidine nucleobase biosynthetic process,1
0,1,4,6,GO:0006208;GO:0046113,nucleobase catabolic process,1
0,1,2,6,GO:0006268,DNA unwinding involved in DNA replication,1
0,1,5,7,GO:0006270,DNA replication initiation,1
0,1,2,6,GO:0006271;GO:0022616,DNA strand elongation,1
0,1,2,19,GO:0006282;GO:2001020,regulation of response to DNA damage stimulus,1
0,1,3,9,GO:0006283,transcription-coupled nucleotide-excision repair,1
0,1,2,8,GO:0006284,base-excision repair,1
0,1,2,17,GO:0006289,nucleotide-excision repair,1
0,1,2,5,GO:0006298,mismatch repair,1
0,1,6,9,GO:0006301,postreplication repair,1
0,1,2,29,GO:0006302,double-strand break repair,1
0,1,2,101,GO:0006310,DNA recombination,1
0,1,6,6,GO:0006312,mitotic recombination,1
0,1,3,7,GO:0006337;GO:0032986,nucleosome disassembly,1
0,1,2,85,GO:0006364;GO:0016072,rRNA metabolic process,1
0,1,2,9,GO:0006369,termination of RNA polymerase II transcription,1
0,1,3,9,GO:0006370;GO:0009452;GO:0036260,7-methylguanosine mRNA capping,1
0,1,3,14,GO:0006376,mRNA splice site selection,1
0,1,7,5,GO:0006383,transcription by RNA polymerase III,1
0,1,2,5,GO:0006400,tRNA modification,1
0,1,2,8,GO:0006403;GO:0008298,RNA localization,1
0,1,2,5,GO:0006434,seryl-tRNA aminoacylation,1
0,1,2,5,GO:0006438,valyl-tRNA aminoacylation,1
0,1,3,38,GO:0006470;GO:0016311,dephosphorylation,1
0,1,2,48,GO:0006475;GO:0006473;GO:0043543,protein acylation,1
0,1,5,66,GO:0006486;GO:0043413;GO:0070085,protein glycosylation,1
0,1,3,6,GO:0006488;GO:0006490,oligosaccharide-lipid intermediate biosynthetic process,1
0,1,2,16,GO:0006493,protein O-linked glycosylation,1
0,1,2,16,GO:0006497,protein lipidation,1
0,1,5,7,GO:0006509,membrane protein ectodomain proteolysis,1
0,1,5,5,GO:0006515,protein quality control for misfolded or incompletely synthesized proteins,1
0,1,4,7,GO:0006516,glycoprotein catabolic process,1
0,1,2,8,GO:0006534,cysteine metabolic process,1
0,1,6,12,GO:0006536,glutamate metabolic process,1
0,1,3,10,GO:0006544,glycine metabolic process,1
0,1,2,5,GO:0006547;GO:0052803,histidine metabolic process,1
0,1,6,9,GO:0006559;GO:0006558;GO:1902222;GO:1902221;GO:0006570;GO:0006572,L-phenylalanine metabolic process,1
0,1,2,7,GO:0006561;GO:0006560,proline metabolic process,1
0,1,2,6,GO:0006563,L-serine metabolic process,1
0,1,2,52,GO:0006575,cellular modified amino acid metabolic process,1
0,1,3,14,GO:0006576;GO:0044106;GO:0009308,amine metabolic process,1
0,1,4,6,GO:0006595;GO:0042401;GO:0009309,amine biosynthetic process,1
0,1,2,8,GO:0006607;GO:0006610,NLS-bearing protein import into nucleus,1
0,1,4,23,GO:0006612,protein targeting to membrane,1
0,1,2,6,GO:0006614;GO:0006613,cotranslational protein targeting to membrane,1
0,1,4,8,GO:0006620,posttranslational protein targeting to endoplasmic reticulum membrane,1
0,1,3,9,GO:0006626,protein targeting to mitochondrion,1
0,1,2,20,GO:0006635;GO:0009062;GO:0019395;GO:0034440,fatty acid oxidation,1
0,1,3,13,GO:0006637;GO:0035383,acyl-CoA metabolic process,1
0,1,4,20,GO:0006641;GO:0006639;GO:0006638,neutral lipid metabolic process,1
0,1,5,38,GO:0006650,glycerophospholipid metabolic process,1
0,1,2,5,GO:0006654;GO:0046473,phosphatidic acid biosynthetic process,1
0,1,2,10,GO:0006661,phosphatidylinositol biosynthetic process,1
0,1,2,5,GO:0006670;GO:0046519,sphingosine metabolic process,1
0,1,4,7,GO:0006684,sphingomyelin metabolic process,1
0,1,2,10,GO:0006695;GO:0016126;GO:1902653,sterol biosynthetic process,1
0,1,5,9,GO:0006703,estrogen biosynthetic process,1
0,1,4,16,GO:0006720,isoprenoid metabolic process,1
0,1,2,12,GO:0006739,NADP metabolic process,1
0,1,2,8,GO:0006744;GO:0006743;GO:1901663;GO:0042181,ketone biosynthetic process,1
0,1,3,22,GO:0006749,glutathione metabolic process,1
0,1,2,16,GO:0006750;GO:0019184,nonribosomal peptide biosynthetic process,1
0,1,2,11,GO:0006760;GO:0046653,folic acid-containing compound metabolic process,1
0,1,2,16,GO:0006783;GO:0006779;GO:0033014,porphyrin-containing compound biosynthetic process,1
0,1,3,11,GO:0006805,xenobiotic metabolic process,1
0,1,2,11,GO:0006813,potassium ion transport,1
0,1,2,38,GO:0006814,sodium ion transport,1
0,1,3,25,GO:0006816,calcium ion transport,1
0,1,2,5,GO:0006824,cobalt ion transport,1
0,1,2,12,GO:0006825,copper ion transport,1
0,1,2,16,GO:0006829,zinc ion transport,1
0,1,5,7,GO:0006833;GO:0042044,fluid transport,1
0,1,4,5,GO:0006835,dicarboxylic acid transport,1
0,1,2,26,GO:0006839,mitochondrial transport,1
0,1,2,7,GO:0006878;GO:0055070,copper ion homeostasis,1
0,1,3,7,GO:0006884,cell volume homeostasis,1
0,1,4,68,GO:0006887,exocytosis,1
0,1,6,7,GO:0006891,intra-Golgi vesicle-mediated transport,1
0,1,2,28,GO:0006893;GO:0098876;GO:0043001;GO:0061951;GO:0072659;GO:1990778,Golgi to plasma membrane transport,1
0,1,2,11,GO:0006901,vesicle coating,1
0,1,2,6,GO:0006903,vesicle targeting,1
0,1,3,38,GO:0006906;GO:0090174;GO:0048284;GO:0061025,organelle fusion,1
0,1,3,24,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,1
0,1,4,11,GO:0006921,cellular component disassembly involved in execution phase of apoptosis,1
0,1,2,33,GO:0006935;GO:0042330,taxis,1
0,1,3,34,GO:0006936;GO:0003012,muscle system process,1
0,1,5,7,GO:0006939,smooth muscle contraction,1
0,1,4,17,GO:0006941,striated muscle contraction,1
0,1,2,18,GO:0006953;GO:0002526,acute inflammatory response,1
0,1,6,21,GO:0006957;GO:0006956,complement activation,1
0,1,2,7,GO:0006970,response to osmotic stress,1
0,1,6,13,GO:0006977;GO:0072431;GO:1902400;GO:1902402;GO:0072422;GO:0072401;GO:0072395;GO:1902403;GO:0072413;GO:0051437;GO:0006521;GO:0033238,obsolete positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,1
0,1,4,5,GO:0006997,nucleus organization,1
0,1,2,39,GO:0007005,mitochondrion organization,1
0,1,2,12,GO:0007006,mitochondrial membrane organization,1
0,1,3,6,GO:0007020,microtubule nucleation,1
0,1,3,5,GO:0007029,endoplasmic reticulum organization,1
0,1,2,11,GO:0007031,peroxisome organization,1
0,1,2,10,GO:0007032,endosome organization,1
0,1,4,6,GO:0007035;GO:0051452;GO:0045851,pH reduction,1
0,1,4,11,GO:0007040;GO:0080171,lysosome organization,1
0,1,2,24,GO:0007051,spindle organization,1
0,1,2,11,GO:0007052,mitotic spindle organization,1
0,1,2,6,GO:0007062,sister chromatid cohesion,1
0,1,2,14,GO:0007076,mitotic chromosome condensation,1
0,1,-1,6,GO:0007090,obsolete regulation of S phase of mitotic cell cycle,1
0,1,2,23,GO:0007093,mitotic cell cycle checkpoint,1
0,1,5,10,GO:0007094;GO:0045841;GO:0071173;GO:0071174;GO:1902100;GO:2000816;GO:0031577;GO:0033048;GO:1905819;GO:0033046;GO:0045839;GO:0051985,negative regulation of mitotic nuclear division,1
0,1,5,7,GO:0007095;GO:0044818;GO:0010972;GO:1902750,negative regulation of cell cycle G2/M phase transition,1
0,1,3,11,GO:0007097;GO:0051647,nucleus localization,1
0,1,2,5,GO:0007130;GO:0070193,synaptonemal complex assembly,1
0,1,6,6,GO:0007131;GO:0035825,homologous recombination,1
0,1,3,7,GO:0007140;GO:0140013;GO:0000280,meiotic nuclear division,1
0,1,2,8,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,1
0,1,2,5,GO:0007158,neuron cell-cell adhesion,1
0,1,4,23,GO:0007160,cell-matrix adhesion,1
0,1,3,29,GO:0007173;GO:0038127,epidermal growth factor receptor signaling pathway,1
0,1,6,33,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,1
0,1,2,23,GO:0007179,transforming growth factor beta receptor signaling pathway,1
0,1,3,14,GO:0007205,protein kinase C-activating G protein-coupled receptor signaling pathway,1
0,1,5,15,GO:0007213;GO:0095500;GO:1903831,acetylcholine receptor signaling pathway,1
0,1,2,11,GO:0007220,Notch receptor processing,1
0,1,2,6,GO:0007224,smoothened signaling pathway,1
0,1,8,16,GO:0007250;GO:1901224;GO:1901222,activation of NF-kappaB-inducing kinase activity,1
0,1,2,14,GO:0007257,activation of JUN kinase activity,1
0,1,3,6,GO:0007279,pole cell formation,1
0,1,2,38,GO:0007281,germ cell development,1
0,1,5,7,GO:0007301;GO:0030725;GO:0043063;GO:0030723,female germline ring canal formation,1
0,1,3,13,GO:0007338;GO:0009566,fertilization,1
0,1,2,16,GO:0007349,cellularization,1
0,1,4,17,GO:0007368;GO:0009855;GO:0009799,determination of bilateral symmetry,1
0,1,4,7,GO:0007398,ectoderm development,1
0,1,2,5,GO:0007406;GO:2000647,negative regulation of neuroblast proliferation,1
0,1,2,41,GO:0007409,axonogenesis,1
0,1,2,6,GO:0007413;GO:0106030,axonal fasciculation,1
0,1,2,6,GO:0007416,synapse assembly,1
0,1,2,12,GO:0007422,peripheral nervous system development,1
0,1,4,11,GO:0007424;GO:0060541,open tracheal system development,1
0,1,3,9,GO:0007435;GO:0022612,salivary gland morphogenesis,1
0,1,3,8,GO:0007440,foregut morphogenesis,1
0,1,2,11,GO:0007444,imaginal disc development,1
0,1,2,6,GO:0007476;GO:0035114;GO:0035120,imaginal disc-derived appendage morphogenesis,1
0,1,2,21,GO:0007492,endoderm development,1
0,1,4,16,GO:0007498,mesoderm development,1
0,1,5,6,GO:0007512,adult heart development,1
0,1,2,20,GO:0007517;GO:0061061,muscle organ development,1
0,1,4,11,GO:0007519,skeletal muscle tissue development,1
0,1,3,5,GO:0007530,sex determination,1
0,1,3,9,GO:0007548,sex differentiation,1
0,1,2,17,GO:0007584,response to nutrient,1
0,1,2,11,GO:0007585,respiratory gaseous exchange,1
0,1,2,14,GO:0007586,digestion,1
0,1,3,7,GO:0007588,excretion,1
0,1,2,7,GO:0007595,lactation,1
0,1,2,54,GO:0007605;GO:0050954,sensory perception of sound,1
0,1,3,14,GO:0007612,learning,1
0,1,2,12,GO:0007616;GO:0007613,memory,1
0,1,2,6,GO:0007619,courtship behavior,1
0,1,2,6,GO:0007632,visual behavior,1
0,1,2,17,GO:0007635,chemosensory behavior,1
0,1,2,8,GO:0007638,mechanosensory behavior,1
0,1,2,5,GO:0008015,blood circulation,1
0,1,2,29,GO:0008033,tRNA processing,1
0,1,2,12,GO:0008045,motor neuron axon guidance,1
0,1,2,19,GO:0008088,axo-dendritic transport,1
0,1,4,5,GO:0008090,retrograde axonal transport,1
0,1,4,5,GO:0008156,negative regulation of DNA replication,1
0,1,4,5,GO:0008207,C21-steroid hormone metabolic process,1
0,1,2,16,GO:0008217,regulation of blood pressure,1
0,1,4,5,GO:0008258,head involution,1
0,1,2,14,GO:0008277,regulation of G protein-coupled receptor signaling pathway,1
0,1,2,9,GO:0008299,isoprenoid biosynthetic process,1
0,1,2,8,GO:0008306,associative learning,1
0,1,4,20,GO:0008333,endosome to lysosome transport,1
0,1,2,8,GO:0008347,glial cell migration,1
0,1,3,10,GO:0008354,germ cell migration,1
0,1,2,15,GO:0008356,asymmetric cell division,1
0,1,2,21,GO:0008406,gonad development,1
0,1,2,9,GO:0008407,chaeta morphogenesis,1
0,1,7,8,GO:0008535,respiratory chain complex IV assembly,1
0,1,6,7,GO:0008582;GO:1904396,regulation of neuromuscular junction development,1
0,1,3,5,GO:0008584,male gonad development,1
0,1,3,5,GO:0008585,female gonad development,1
0,1,2,35,GO:0008593,regulation of Notch signaling pathway,1
0,1,-1,7,GO:0008633,obsolete activation of pro-apoptotic gene products,1
0,1,4,5,GO:0008635,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,1
0,1,5,6,GO:0008637,apoptotic mitochondrial changes,1
0,1,5,6,GO:0008643,carbohydrate transport,1
0,1,2,46,GO:0008654,phospholipid biosynthetic process,1
0,1,5,6,GO:0009060;GO:0045333,aerobic respiration,1
0,1,2,35,GO:0009063;GO:1901606,cellular amino acid catabolic process,1
0,1,7,9,GO:0009065,glutamine family amino acid catabolic process,1
0,1,2,25,GO:0009069,serine family amino acid metabolic process,1
0,1,3,11,GO:0009070,serine family amino acid biosynthetic process,1
0,1,5,18,GO:0009072,aromatic amino acid family metabolic process,1
0,1,2,5,GO:0009073,aromatic amino acid family biosynthetic process,1
0,1,4,13,GO:0009074,aromatic amino acid family catabolic process,1
0,1,4,12,GO:0009081,branched-chain amino acid metabolic process,1
0,1,5,8,GO:0009083,branched-chain amino acid catabolic process,1
0,1,2,22,GO:0009100,glycoprotein metabolic process,1
0,1,3,5,GO:0009101,glycoprotein biosynthetic process,1
0,1,5,9,GO:0009109,coenzyme catabolic process,1
0,1,2,26,GO:0009112,nucleobase metabolic process,1
0,1,3,7,GO:0009113,purine nucleobase biosynthetic process,1
0,1,3,6,GO:0009154;GO:0006195;GO:0009261,ribonucleotide catabolic process,1
0,1,6,14,GO:0009156;GO:0009124;GO:0009161;GO:0009123,ribonucleoside monophosphate metabolic process,1
0,1,2,11,GO:0009163;GO:1901659,nucleoside biosynthetic process,1
0,1,6,10,GO:0009168;GO:0009127;GO:0009167;GO:0009126,purine nucleoside monophosphate biosynthetic process,1
0,1,3,9,GO:0009220;GO:0009218,pyrimidine ribonucleotide metabolic process,1
0,1,5,6,GO:0009258;GO:0009256;GO:0009397;GO:0043649;GO:0042219;GO:0042560,dicarboxylic acid catabolic process,1
0,1,2,8,GO:0009268,response to pH,1
0,1,6,9,GO:0009303;GO:0098781,ncRNA transcription,1
0,1,3,6,GO:0009311,oligosaccharide metabolic process,1
0,1,3,16,GO:0009395,phospholipid catabolic process,1
0,1,3,15,GO:0009405,pathogenesis,1
0,1,2,8,GO:0009409,response to cold,1
0,1,3,10,GO:0009410,response to xenobiotic stimulus,1
0,1,2,23,GO:0009411,response to UV,1
0,1,5,21,GO:0009451,RNA modification,1
0,1,3,26,GO:0009593,detection of chemical stimulus,1
0,1,5,5,GO:0009597,detection of virus,1
0,1,2,37,GO:0009636,response to toxic substance,1
0,1,2,5,GO:0009737,response to abscisic acid,1
0,1,2,8,GO:0009751,response to salicylic acid,1
0,1,2,5,GO:0009826,unidimensional cell growth,1
0,1,2,8,GO:0009847,spore germination,1
0,1,4,11,GO:0009914;GO:0046879,hormone transport,1
0,1,2,5,GO:0009949;GO:0065001,polarity specification of anterior/posterior axis,1
0,1,4,8,GO:0009950,dorsal/ventral axis specification,1
0,1,2,9,GO:0009954,proximal/distal pattern formation,1
0,1,2,22,GO:0010001,glial cell differentiation,1
0,1,2,5,GO:0010002,cardioblast differentiation,1
0,1,5,6,GO:0010039,response to iron ion,1
0,1,3,9,GO:0010043,response to zinc ion,1
0,1,2,14,GO:0010171,body morphogenesis,1
0,1,3,6,GO:0010172,embryonic body morphogenesis,1
0,1,3,5,GO:0010225,response to UV-C,1
0,1,7,10,GO:0010389;GO:1902749,regulation of cell cycle G2/M phase transition,1
0,1,5,14,GO:0010453,regulation of cell fate commitment,1
0,1,2,9,GO:0010454,negative regulation of cell fate commitment,1
0,1,2,15,GO:0010506,regulation of autophagy,1
0,1,3,10,GO:0010508,positive regulation of autophagy,1
0,1,3,15,GO:0010517;GO:0060191,regulation of lipase activity,1
0,1,3,9,GO:0010518;GO:0060193,positive regulation of lipase activity,1
0,1,2,23,GO:0010565,regulation of cellular ketone metabolic process,1
0,1,2,7,GO:0010575;GO:0010574,positive regulation of vascular endothelial growth factor production,1
0,1,3,8,GO:0010591;GO:1902743,regulation of lamellipodium organization,1
0,1,2,9,GO:0010623,programmed cell death involved in cell development,1
0,1,3,37,GO:0010632,regulation of epithelial cell migration,1
0,1,3,6,GO:0010633,negative regulation of epithelial cell migration,1
0,1,2,20,GO:0010634,positive regulation of epithelial cell migration,1
0,1,4,25,GO:0010810;GO:0001952,regulation of cell-substrate adhesion,1
0,1,2,6,GO:0010812,negative regulation of cell-substrate adhesion,1
0,1,6,7,GO:0010821,regulation of mitochondrion organization,1
0,1,2,5,GO:0010863;GO:1900274,positive regulation of phospholipase C activity,1
0,1,4,8,GO:0010867;GO:0010866;GO:0046889,regulation of triglyceride biosynthetic process,1
0,1,3,10,GO:0010888;GO:0010883;GO:1905953,regulation of lipid storage,1
0,1,6,7,GO:0010891;GO:0010889;GO:0010898;GO:0010896;GO:0050996,positive regulation of lipid catabolic process,1
0,1,2,5,GO:0010912;GO:0010911,positive regulation of isomerase activity,1
0,1,2,44,GO:0010948;GO:0045930,negative regulation of mitotic cell cycle,1
0,1,4,32,GO:0010970;GO:0030705;GO:0099111,transport along microtubule,1
0,1,2,6,GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,1
0,1,4,82,GO:0014070,response to organic cyclic compound,1
0,1,5,15,GO:0014074;GO:0046683,response to purine-containing compound,1
0,1,5,6,GO:0014075,response to amine,1
0,1,4,8,GO:0015669,gas transport,1
0,1,5,5,GO:0015696,ammonium transport,1
0,1,2,5,GO:0015698,inorganic anion transport,1
0,1,3,6,GO:0015701,bicarbonate transport,1
0,1,2,5,GO:0015844,monoamine transport,1
0,1,2,18,GO:0015850,organic hydroxy compound transport,1
0,1,2,23,GO:0015893,drug transport,1
0,1,5,6,GO:0015908,fatty acid transport,1
0,1,5,8,GO:0015914;GO:0015748,organophosphate ester transport,1
0,1,2,6,GO:0015919;GO:0016558,peroxisomal membrane transport,1
0,1,2,9,GO:0015936,coenzyme A metabolic process,1
0,1,2,43,GO:0016051,carbohydrate biosynthetic process,1
0,1,3,9,GO:0016180;GO:0016073,snRNA metabolic process,1
0,1,2,6,GO:0016189,synaptic vesicle to endosome fusion,1
0,1,3,10,GO:0016226;GO:0031163,iron-sulfur cluster assembly,1
0,1,2,5,GO:0016246,RNA interference,1
0,1,3,5,GO:0016319,mushroom body development,1
0,1,2,8,GO:0016332,establishment or maintenance of polarity of embryonic epithelium,1
0,1,2,8,GO:0016334,establishment or maintenance of polarity of follicular epithelium,1
0,1,3,5,GO:0016445;GO:0002200,somatic diversification of immunoglobulins,1
0,1,5,16,GO:0016525;GO:2000181;GO:1901343,negative regulation of vasculature development,1
0,1,3,33,GO:0016573;GO:0018393;GO:0018394,internal peptidyl-lysine acetylation,1
0,1,2,7,GO:0016601,Rac protein signal transduction,1
0,1,2,7,GO:0017000,antibiotic biosynthetic process,1
0,1,2,12,GO:0017004,cytochrome complex assembly,1
0,1,2,9,GO:0017145,stem cell division,1
0,1,4,32,GO:0017148;GO:0034249,negative regulation of cellular amide metabolic process,1
0,1,3,12,GO:0017156;GO:0016079,calcium ion regulated exocytosis,1
0,1,2,22,GO:0017157,regulation of exocytosis,1
0,1,2,7,GO:0017158,regulation of calcium ion-dependent exocytosis,1
0,1,2,7,GO:0018065,protein-cofactor linkage,1
0,1,4,15,GO:0018105;GO:0018209,peptidyl-serine modification,1
0,1,3,5,GO:0018107,peptidyl-threonine phosphorylation,1
0,1,6,25,GO:0018108;GO:0018212,peptidyl-tyrosine modification,1
0,1,2,5,GO:0018126,protein hydroxylation,1
0,1,5,9,GO:0018149,peptide cross-linking,1
0,1,3,8,GO:0018200,peptidyl-glutamic acid modification,1
0,1,3,5,GO:0018202,peptidyl-histidine modification,1
0,1,6,7,GO:0018210,peptidyl-threonine modification,1
0,1,3,32,GO:0018279;GO:0006487;GO:0018196,protein N-linked glycosylation,1
0,1,2,5,GO:0018410,C-terminal protein amino acid modification,1
0,1,2,7,GO:0019058,viral life cycle,1
0,1,2,15,GO:0019217,regulation of fatty acid metabolic process,1
0,1,2,9,GO:0019218,regulation of steroid metabolic process,1
0,1,2,5,GO:0019228,neuronal action potential,1
0,1,2,8,GO:0019229,regulation of vasoconstriction,1
0,1,5,13,GO:0019233,sensory perception of pain,1
0,1,3,5,GO:0019377,glycolipid catabolic process,1
0,1,2,7,GO:0019432;GO:0046463;GO:0046460,acylglycerol biosynthetic process,1
0,1,3,5,GO:0019695,choline metabolic process,1
0,1,2,14,GO:0019722,calcium-mediated signaling,1
0,1,2,29,GO:0019751,polyol metabolic process,1
0,1,2,25,GO:0019827;GO:0098727,stem cell population maintenance,1
0,1,2,9,GO:0019835,cytolysis,1
0,1,3,5,GO:0019852,L-ascorbic acid metabolic process,1
0,1,2,7,GO:0019915,lipid storage,1
0,1,2,5,GO:0019985,translesion synthesis,1
0,1,3,5,GO:0021508,floor plate formation,1
0,1,2,11,GO:0021510,spinal cord development,1
0,1,4,11,GO:0021515,cell differentiation in spinal cord,1
0,1,4,6,GO:0021533,cell differentiation in hindbrain,1
0,1,2,8,GO:0021537,telencephalon development,1
0,1,4,8,GO:0021545;GO:0021675,cranial nerve development,1
0,1,2,7,GO:0021549,cerebellum development,1
0,1,2,5,GO:0021670,lateral ventricle development,1
0,1,3,6,GO:0021744;GO:0048857,neural nucleus development,1
0,1,2,7,GO:0021766,hippocampus development,1
0,1,3,12,GO:0021782,glial cell development,1
0,1,2,5,GO:0021794,thalamus development,1
0,1,2,6,GO:0021861;GO:0060019;GO:2000978;GO:2000977,radial glial cell differentiation,1
0,1,3,8,GO:0021952;GO:0021955,central nervous system projection neuron axonogenesis,1
0,1,5,15,GO:0021953,central nervous system neuron differentiation,1
0,1,2,5,GO:0021984,adenohypophysis development,1
0,1,2,12,GO:0021987,cerebral cortex development,1
0,1,4,12,GO:0022008,neurogenesis,1
0,1,5,6,GO:0022011;GO:0032292,myelination in peripheral nervous system,1
0,1,5,5,GO:0022029;GO:0021885,telencephalon cell migration,1
0,1,2,5,GO:0023035,CD40 signaling pathway,1
0,1,2,31,GO:0030010,establishment of cell polarity,1
0,1,2,6,GO:0030042;GO:0051261,protein depolymerization,1
0,1,2,23,GO:0030048,actin filament-based movement,1
0,1,3,8,GO:0030049,muscle filament sliding,1
0,1,4,15,GO:0030071;GO:0010965;GO:1902099;GO:0033047;GO:1905818;GO:0033045,regulation of sister chromatid segregation,1
0,1,2,6,GO:0030072;GO:0030073,peptide hormone secretion,1
0,1,2,39,GO:0030168,platelet activation,1
0,1,5,8,GO:0030174,regulation of DNA-dependent DNA replication initiation,1
0,1,2,27,GO:0030178,negative regulation of Wnt signaling pathway,1
0,1,2,35,GO:0030182,neuron differentiation,1
0,1,4,13,GO:0030199,collagen fibril organization,1
0,1,3,16,GO:0030203,glycosaminoglycan metabolic process,1
0,1,5,16,GO:0030217,T cell differentiation,1
0,1,6,18,GO:0030241;GO:0071688,striated muscle myosin thick filament assembly,1
0,1,4,25,GO:0030258,lipid modification,1
0,1,7,25,GO:0030261;GO:0006323,chromosome condensation,1
0,1,2,8,GO:0030263,apoptotic chromosome condensation,1
0,1,3,30,GO:0030278,regulation of ossification,1
0,1,2,7,GO:0030279,negative regulation of ossification,1
0,1,3,6,GO:0030282,bone mineralization,1
0,1,2,11,GO:0030307,positive regulation of cell growth,1
0,1,2,17,GO:0030324,lung development,1
0,1,2,5,GO:0030325,adrenal gland development,1
0,1,2,20,GO:0030330;GO:0042770,signal transduction in response to DNA damage,1
0,1,3,17,GO:0030336;GO:2000146;GO:0051271,negative regulation of cellular component movement,1
0,1,2,5,GO:0030431,sleep,1
0,1,2,5,GO:0030497;GO:0042761;GO:0000038,fatty acid elongation,1
0,1,4,18,GO:0030500;GO:0070167,regulation of biomineral tissue development,1
0,1,2,17,GO:0030509,BMP signaling pathway,1
0,1,2,9,GO:0030574,collagen catabolic process,1
0,1,5,14,GO:0030595;GO:0060326;GO:0097529,cell chemotaxis,1
0,1,3,10,GO:0030718,germ-line stem cell population maintenance,1
0,1,4,7,GO:0030838,positive regulation of actin filament polymerization,1
0,1,5,27,GO:0030856,regulation of epithelial cell differentiation,1
0,1,2,16,GO:0030858,positive regulation of epithelial cell differentiation,1
0,1,2,7,GO:0030900,forebrain development,1
0,1,2,13,GO:0030901,midbrain development,1
0,1,2,6,GO:0030902,hindbrain development,1
0,1,2,5,GO:0030916,otic vesicle formation,1
0,1,2,12,GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,1
0,1,3,8,GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway,1
0,1,2,5,GO:0030950,establishment or maintenance of actin cytoskeleton polarity,1
0,1,2,8,GO:0030952,establishment or maintenance of cytoskeleton polarity,1
0,1,3,20,GO:0031032,actomyosin structure organization,1
0,1,2,25,GO:0031034;GO:0031033;GO:0010927,cellular component assembly involved in morphogenesis,1
0,1,2,31,GO:0031047,gene silencing by RNA,1
0,1,3,14,GO:0031054,pre-miRNA processing,1
0,1,3,10,GO:0031076,embryonic camera-type eye development,1
0,1,4,13,GO:0031100;GO:0031099,regeneration,1
0,1,3,5,GO:0031103;GO:0031102;GO:0061564,neuron projection regeneration,1
0,1,3,9,GO:0031122,cytoplasmic microtubule organization,1
0,1,6,8,GO:0031128;GO:1905332;GO:0090190;GO:0061213;GO:0090189;GO:0061217,regulation of mesonephros development,1
0,1,2,15,GO:0031145,anaphase-promoting complex-dependent catabolic process,1
0,1,2,5,GO:0031179,peptide modification,1
0,1,2,13,GO:0031214,biomineral tissue development,1
0,1,5,13,GO:0031290,retinal ganglion cell axon guidance,1
0,1,5,6,GO:0031293,membrane protein intracellular domain proteolysis,1
0,1,5,8,GO:0031295;GO:0031294,T cell costimulation,1
0,1,3,15,GO:0031330;GO:0009895,negative regulation of catabolic process,1
0,1,5,10,GO:0031397;GO:1903321,negative regulation of protein modification by small protein conjugation or removal,1
0,1,3,22,GO:0031532,actin cytoskeleton reorganization,1
0,1,2,14,GO:0031572,G2 DNA damage checkpoint,1
0,1,2,5,GO:0031623,receptor internalization,1
0,1,2,10,GO:0031641,regulation of myelination,1
0,1,2,22,GO:0031644,regulation of neurological system process,1
0,1,2,6,GO:0031645,negative regulation of neurological system process,1
0,1,2,10,GO:0031646,positive regulation of neurological system process,1
0,1,3,37,GO:0031667;GO:0009991,response to nutrient levels,1
0,1,4,5,GO:0031952,regulation of protein autophosphorylation,1
0,1,5,21,GO:0031960;GO:0048545,response to steroid hormone,1
0,1,3,16,GO:0032006,regulation of TOR signaling,1
0,1,4,7,GO:0032007,negative regulation of TOR signaling,1
0,1,4,7,GO:0032008,positive regulation of TOR signaling,1
0,1,2,10,GO:0032012,regulation of ARF protein signal transduction,1
0,1,2,6,GO:0032233,positive regulation of actin filament bundle assembly,1
0,1,2,13,GO:0032273;GO:0031334,positive regulation of protein complex assembly,1
0,1,4,17,GO:0032355,response to estradiol,1
0,1,2,5,GO:0032365,intracellular lipid transport,1
0,1,5,8,GO:0032374;GO:0032371;GO:0032368,regulation of lipid transport,1
0,1,4,10,GO:0032411;GO:0032409;GO:0022898,regulation of transmembrane transporter activity,1
0,1,4,7,GO:0032435;GO:1901799;GO:2000059;GO:1903051;GO:1903363,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,1
0,1,3,27,GO:0032480;GO:0032479,regulation of type I interferon production,1
0,1,7,12,GO:0032508;GO:0032392,DNA duplex unwinding,1
0,1,2,21,GO:0032648,regulation of interferon-beta production,1
0,1,2,5,GO:0032653,regulation of interleukin-10 production,1
0,1,5,15,GO:0032663,regulation of interleukin-2 production,1
0,1,7,12,GO:0032727;GO:0032481;GO:0032647;GO:0032728,positive regulation of type I interferon production,1
0,1,2,7,GO:0032743,positive regulation of interleukin-2 production,1
0,1,6,5,GO:0032793,positive regulation of CREB transcription factor activity,1
0,1,4,15,GO:0032801;GO:0001919,regulation of receptor recycling,1
0,1,2,16,GO:0032963,collagen metabolic process,1
0,1,7,5,GO:0032968;GO:0034243,positive regulation of transcription elongation from RNA polymerase II promoter,1
0,1,3,6,GO:0032981;GO:0010257;GO:0033108,mitochondrial respiratory chain complex assembly,1
0,1,2,7,GO:0033003,regulation of mast cell activation,1
0,1,4,6,GO:0033135;GO:0033138,regulation of peptidyl-serine phosphorylation,1
0,1,3,5,GO:0033198,response to ATP,1
0,1,-1,7,GO:0033261,obsolete regulation of S phase,1
0,1,5,5,GO:0033262,regulation of nuclear cell cycle DNA replication,1
0,1,2,12,GO:0033275;GO:0070252,actin-mediated cell contraction,1
0,1,6,11,GO:0033344;GO:0030301;GO:0015918,sterol transport,1
0,1,3,8,GO:0033345;GO:0006530;GO:0006528;GO:0009068,asparagine metabolic process,1
0,1,2,12,GO:0033619,membrane protein proteolysis,1
0,1,4,16,GO:0033692;GO:0000271;GO:0034637,cellular carbohydrate biosynthetic process,1
0,1,3,22,GO:0033875;GO:0034032;GO:0033865,purine nucleoside bisphosphate metabolic process,1
0,1,2,11,GO:0034030;GO:0034033;GO:0033866,ribonucleoside bisphosphate biosynthetic process,1
0,1,4,6,GO:0034308,primary alcohol metabolic process,1
0,1,3,12,GO:0034311,diol metabolic process,1
0,1,2,10,GO:0034312;GO:0046173,polyol biosynthetic process,1
0,1,2,5,GO:0034341,response to interferon-gamma,1
0,1,2,8,GO:0034394,protein localization to cell surface,1
0,1,2,7,GO:0034446,substrate adhesion-dependent cell spreading,1
0,1,2,128,GO:0034470,ncRNA processing,1
0,1,2,11,GO:0034612,response to tumor necrosis factor,1
0,1,3,6,GO:0034644;GO:0071482,cellular response to light stimulus,1
0,1,3,7,GO:0035019,somatic stem cell population maintenance,1
0,1,2,8,GO:0035050;GO:0008078,embryonic heart tube development,1
0,1,2,10,GO:0035051,cardiocyte differentiation,1
0,1,4,21,GO:0035113,embryonic appendage morphogenesis,1
0,1,2,22,GO:0035176;GO:0051703,intraspecies interaction between organisms,1
0,1,6,7,GO:0035194;GO:0016441,posttranscriptional gene silencing,1
0,1,2,11,GO:0035235,ionotropic glutamate receptor signaling pathway,1
0,1,2,8,GO:0035265,organ growth,1
0,1,6,20,GO:0035278;GO:0040033;GO:0045974;GO:0045947,miRNA mediated inhibition of translation,1
0,1,9,14,GO:0035279;GO:0098795;GO:0006379;GO:0090501,mRNA cleavage,1
0,1,2,12,GO:0035282;GO:0001756,segmentation,1
0,1,4,11,GO:0035303,regulation of dephosphorylation,1
0,1,5,5,GO:0035315,hair cell differentiation,1
0,1,8,5,GO:0035338;GO:0035336,long-chain fatty-acyl-CoA biosynthetic process,1
0,1,2,5,GO:0035419,activation of MAPK activity involved in innate immune response,1
0,1,5,5,GO:0035456,response to interferon-beta,1
0,1,4,5,GO:0035459,vesicle cargo loading,1
0,1,4,8,GO:0035564,regulation of kidney size,1
0,1,2,9,GO:0035567,non-canonical Wnt signaling pathway,1
0,1,3,19,GO:0035583;GO:0030512;GO:0035581;GO:0071694;GO:0017015;GO:1903845;GO:1903844;GO:1900116;GO:1900115,regulation of transforming growth factor beta receptor signaling pathway,1
0,1,2,8,GO:0035640,exploration behavior,1
0,1,4,8,GO:0035690,cellular response to drug,1
0,1,3,10,GO:0035821,modification of morphology or physiology of other organism,1
0,1,2,19,GO:0040013,negative regulation of locomotion,1
0,1,2,66,GO:0040017;GO:0030335;GO:2000147;GO:0051272,positive regulation of cellular component movement,1
0,1,2,5,GO:0040018,positive regulation of multicellular organism growth,1
0,1,2,5,GO:0040019,positive regulation of embryonic development,1
0,1,2,12,GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,1
0,1,2,6,GO:0042036,negative regulation of cytokine biosynthetic process,1
0,1,3,8,GO:0042048,olfactory behavior,1
0,1,6,8,GO:0042051,compound eye photoreceptor development,1
0,1,4,15,GO:0042060,wound healing,1
0,1,2,24,GO:0042133,neurotransmitter metabolic process,1
0,1,4,6,GO:0042135,neurotransmitter catabolic process,1
0,1,3,9,GO:0042136,neurotransmitter biosynthetic process,1
0,1,2,8,GO:0042157,lipoprotein metabolic process,1
0,1,4,10,GO:0042177,negative regulation of protein catabolic process,1
0,1,2,17,GO:0042180,cellular ketone metabolic process,1
0,1,3,8,GO:0042255,ribosome assembly,1
0,1,2,8,GO:0042359;GO:0006775,fat-soluble vitamin metabolic process,1
0,1,2,24,GO:0042398,cellular modified amino acid biosynthetic process,1
0,1,3,28,GO:0042446,hormone biosynthetic process,1
0,1,5,12,GO:0042462;GO:0042461,eye photoreceptor cell development,1
0,1,2,12,GO:0042472,inner ear morphogenesis,1
0,1,3,15,GO:0042542,response to hydrogen peroxide,1
0,1,3,5,GO:0042554,superoxide anion generation,1
0,1,2,16,GO:0042558,pteridine-containing compound metabolic process,1
0,1,2,6,GO:0042559,pteridine-containing compound biosynthetic process,1
0,1,2,20,GO:0042594;GO:0031669;GO:0031668;GO:0009267,response to starvation,1
0,1,6,11,GO:0042632;GO:0055092,sterol homeostasis,1
0,1,2,8,GO:0042659,regulation of cell fate specification,1
0,1,2,18,GO:0042692,muscle cell differentiation,1
0,1,3,8,GO:0042710;GO:0000128;GO:0098630;GO:0001403;GO:0036267;GO:0070783;GO:0044182;GO:0030447;GO:0007124,aggregation of unicellular organisms,1
0,1,4,23,GO:0042730;GO:0030195;GO:0030193;GO:0050819;GO:0061045;GO:1900047;GO:0050818;GO:1900046;GO:1903035,regulation of coagulation,1
0,1,2,56,GO:0042737,drug catabolic process,1
0,1,2,32,GO:0042744;GO:0017001;GO:0042743,hydrogen peroxide metabolic process,1
0,1,2,9,GO:0042771;GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,1
0,1,3,9,GO:0042987;GO:0042982,amyloid precursor protein metabolic process,1
0,1,-1,6,GO:0042993,obsolete positive regulation of transcription factor import into nucleus,1
0,1,2,11,GO:0043046;GO:0034587,piRNA metabolic process,1
0,1,2,54,GO:0043062;GO:0030198,extracellular structure organization,1
0,1,4,92,GO:0043066;GO:0043069;GO:0060548,negative regulation of cell death,1
0,1,3,6,GO:0043101,purine-containing compound salvage,1
0,1,4,17,GO:0043112,receptor metabolic process,1
0,1,2,20,GO:0043113;GO:0051668,localization within membrane,1
0,1,2,9,GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling,1
0,1,5,9,GO:0043152,induction of bacterial agglutination,1
0,1,2,5,GO:0043174,nucleoside salvage,1
0,1,2,20,GO:0043200,response to amino acid,1
0,1,2,17,GO:0043270,positive regulation of ion transport,1
0,1,5,6,GO:0043279,response to alkaloid,1
0,1,2,33,GO:0043280;GO:0043281;GO:2001056;GO:2000116;GO:0052548;GO:0052547;GO:0010950;GO:0010952,regulation of endopeptidase activity,1
0,1,3,8,GO:0043388,positive regulation of DNA binding,1
0,1,2,7,GO:0043462,regulation of ATPase activity,1
0,1,1,16,GO:0043473,pigmentation,1
0,1,2,30,GO:0043523;GO:1901214,regulation of neuron apoptotic process,1
0,1,5,22,GO:0043524;GO:1901215,negative regulation of neuron apoptotic process,1
0,1,7,7,GO:0043525;GO:1901216,positive regulation of neuron apoptotic process,1
0,1,-1,7,GO:0043526,obsolete neuroprotection,1
0,1,4,5,GO:0043552;GO:0043551;GO:0090218;GO:1903727;GO:0043550;GO:1903725,regulation of phosphatidylinositol 3-kinase activity,1
0,1,4,8,GO:0043574;GO:0006625;GO:0072663;GO:0072662,peroxisomal transport,1
0,1,2,7,GO:0043588,skin development,1
0,1,2,17,GO:0043627,response to estrogen,1
0,1,3,7,GO:0043666;GO:0010921;GO:0035304;GO:0035507,regulation of phosphoprotein phosphatase activity,1
0,1,3,27,GO:0043687,post-translational protein modification,1
0,1,2,17,GO:0043901,negative regulation of multi-organism process,1
0,1,5,9,GO:0043966,histone H3 acetylation,1
0,1,5,17,GO:0043967,histone H4 acetylation,1
0,1,2,11,GO:0043968,histone H2A acetylation,1
0,1,2,6,GO:0044036,cell wall macromolecule metabolic process,1
0,1,3,48,GO:0044057,regulation of system process,1
0,1,2,29,GO:0044089,positive regulation of cellular component biogenesis,1
0,1,3,6,GO:0044179;GO:0051715;GO:0031640;GO:0001906;GO:0044364,cell killing,1
0,1,3,7,GO:0044550,secondary metabolite biosynthetic process,1
0,1,2,8,GO:0044703,multi-organism reproductive process,1
0,1,2,6,GO:0044706;GO:0007565,multi-multicellular organism process,1
0,1,2,14,GO:0044764,multi-organism cellular process,1
0,1,2,56,GO:0044772;GO:0044770,mitotic cell cycle phase transition,1
0,1,2,12,GO:0044773;GO:0044774,mitotic DNA integrity checkpoint,1
0,1,2,36,GO:0045017,glycerolipid biosynthetic process,1
0,1,5,25,GO:0045022;GO:0098927,vesicle-mediated transport between endosomal compartments,1
0,1,5,14,GO:0045047;GO:0072599;GO:0070972,protein targeting to ER,1
0,1,2,29,GO:0045055,regulated exocytosis,1
0,1,7,6,GO:0045069;GO:1903900,regulation of viral genome replication,1
0,1,7,6,GO:0045116,protein neddylation,1
0,1,5,6,GO:0045123;GO:0030593;GO:0071621;GO:1990266;GO:0097530,cellular extravasation,1
0,1,4,10,GO:0045124;GO:0046850;GO:0034103,regulation of bone resorption,1
0,1,5,23,GO:0045162;GO:0045161,neuronal ion channel clustering,1
0,1,3,20,GO:0045197;GO:0035088;GO:0061245,establishment or maintenance of bipolar cell polarity,1
0,1,2,9,GO:0045198;GO:0030859;GO:0035089;GO:0061162;GO:0061339,polarized epithelial cell differentiation,1
0,1,5,8,GO:0045199;GO:0035090,maintenance of apical/basal cell polarity,1
0,1,5,5,GO:0045332;GO:0034204;GO:0097035,phospholipid translocation,1
0,1,4,13,GO:0045444,fat cell differentiation,1
0,1,2,11,GO:0045446,endothelial cell differentiation,1
0,1,4,6,GO:0045471,response to ethanol,1
0,1,3,6,GO:0045582;GO:0045621,positive regulation of T cell differentiation,1
0,1,5,11,GO:0045598,regulation of fat cell differentiation,1
0,1,3,5,GO:0045599,negative regulation of fat cell differentiation,1
0,1,2,10,GO:0045648;GO:0045646,regulation of erythrocyte differentiation,1
0,1,6,23,GO:0045669;GO:0045667;GO:0045778,regulation of osteoblast differentiation,1
0,1,3,6,GO:0045682,regulation of epidermis development,1
0,1,4,14,GO:0045727;GO:0034250,positive regulation of cellular amide metabolic process,1
0,1,7,9,GO:0045736;GO:1904030,negative regulation of cyclin-dependent protein serine/threonine kinase activity,1
0,1,2,11,GO:0045739;GO:2001022,positive regulation of DNA repair,1
0,1,2,18,GO:0045740,positive regulation of DNA replication,1
0,1,3,8,GO:0045743,positive regulation of fibroblast growth factor receptor signaling pathway,1
0,1,3,12,GO:0045746,negative regulation of Notch signaling pathway,1
0,1,3,18,GO:0045747,positive regulation of Notch signaling pathway,1
0,1,5,49,GO:0045765;GO:1901342,regulation of vasculature development,1
0,1,3,22,GO:0045766;GO:1904018,positive regulation of angiogenesis,1
0,1,-1,6,GO:0045768,obsolete positive regulation of anti-apoptosis,1
0,1,2,11,GO:0045807,positive regulation of endocytosis,1
0,1,5,12,GO:0045821;GO:0006110;GO:0030813;GO:0045913;GO:0051197;GO:2001171;GO:0030811;GO:0043470;GO:0051196;GO:2001169;GO:0051193;GO:1900371;GO:1903578;GO:0030808;GO:0045981;GO:0051194;GO:1900373;GO:1903580;GO:0030810;GO:1900544;GO:0062013,regulation of cofactor metabolic process,1
0,1,2,18,GO:0045834,positive regulation of lipid metabolic process,1
0,1,4,12,GO:0045861,negative regulation of proteolysis,1
0,1,7,5,GO:0045907,positive regulation of vasoconstriction,1
0,1,2,5,GO:0045910,negative regulation of DNA recombination,1
0,1,2,5,GO:0045921,positive regulation of exocytosis,1
0,1,2,7,GO:0045931,positive regulation of mitotic cell cycle,1
0,1,2,14,GO:0046112,nucleobase biosynthetic process,1
0,1,2,13,GO:0046128;GO:0009119;GO:0042278,ribonucleoside metabolic process,1
0,1,4,8,GO:0046129;GO:0042451;GO:0042455,ribonucleoside biosynthetic process,1
0,1,4,6,GO:0046146,tetrahydrobiopterin metabolic process,1
0,1,3,22,GO:0046148,pigment biosynthetic process,1
0,1,4,22,GO:0046165,alcohol biosynthetic process,1
0,1,3,5,GO:0046184,aldehyde biosynthetic process,1
0,1,2,6,GO:0046189,phenol-containing compound biosynthetic process,1
0,1,3,9,GO:0046320,regulation of fatty acid oxidation,1
0,1,3,9,GO:0046331;GO:0045168,cell-cell signaling involved in cell fate commitment,1
0,1,3,59,GO:0046395;GO:0016054,carboxylic acid catabolic process,1
0,1,2,12,GO:0046425;GO:1904892,regulation of receptor signaling pathway via JAK-STAT,1
0,1,5,6,GO:0046464;GO:0046461;GO:0046503;GO:0019433,glycerolipid catabolic process,1
0,1,2,7,GO:0046470,phosphatidylcholine metabolic process,1
0,1,3,24,GO:0046474,glycerophospholipid biosynthetic process,1
0,1,4,60,GO:0046486,glycerolipid metabolic process,1
0,1,2,17,GO:0046488,phosphatidylinositol metabolic process,1
0,1,2,6,GO:0046500,S-adenosylmethionine metabolic process,1
0,1,2,10,GO:0046532;GO:0046533,regulation of photoreceptor cell differentiation,1
0,1,4,15,GO:0046579;GO:0051057,positive regulation of small GTPase mediated signal transduction,1
0,1,5,10,GO:0046580;GO:0051058,negative regulation of Ras protein signal transduction,1
0,1,2,14,GO:0046620,regulation of organ growth,1
0,1,2,9,GO:0046622,positive regulation of organ growth,1
0,1,3,39,GO:0046677,response to antibiotic,1
0,1,2,6,GO:0046797,viral procapsid maturation,1
0,1,2,15,GO:0046847,filopodium assembly,1
0,1,6,7,GO:0046886;GO:0032352;GO:0046885;GO:0032350,regulation of hormone metabolic process,1
0,1,5,6,GO:0046888,negative regulation of hormone secretion,1
0,1,2,13,GO:0046890,regulation of lipid biosynthetic process,1
0,1,4,5,GO:0046902;GO:0090559,regulation of mitochondrial membrane permeability,1
0,1,2,8,GO:0046928;GO:0051588,regulation of neurotransmitter transport,1
0,1,7,7,GO:0046949;GO:0035337;GO:0071616;GO:0035384,acyl-CoA biosynthetic process,1
0,1,5,9,GO:0047496;GO:0099518;GO:0072383;GO:0072386,vesicle cytoskeletal trafficking,1
0,1,4,11,GO:0048009,insulin-like growth factor receptor signaling pathway,1
0,1,3,19,GO:0048015;GO:0048017,inositol lipid-mediated signaling,1
0,1,6,16,GO:0048025;GO:0033119;GO:0050686;GO:1903312,negative regulation of mRNA metabolic process,1
0,1,2,9,GO:0048041;GO:0007045;GO:0034333,focal adhesion assembly,1
0,1,5,10,GO:0048048,embryonic eye morphogenesis,1
0,1,4,7,GO:0048134;GO:0007294;GO:0030716,oocyte fate determination,1
0,1,2,7,GO:0048145,regulation of fibroblast proliferation,1
0,1,4,5,GO:0048147,negative regulation of fibroblast proliferation,1
0,1,2,22,GO:0048167,regulation of synaptic plasticity,1
0,1,6,18,GO:0048169;GO:0048168,regulation of neuronal synaptic plasticity,1
0,1,2,9,GO:0048170,positive regulation of long-term neuronal synaptic plasticity,1
0,1,4,9,GO:0048190;GO:0007450;GO:0035222;GO:0007447,imaginal disc pattern formation,1
0,1,3,7,GO:0048208,COPII vesicle coating,1
0,1,2,20,GO:0048211;GO:0035493;GO:0048280,vesicle fusion with Golgi apparatus,1
0,1,2,6,GO:0048251;GO:0085029,elastic fiber assembly,1
0,1,6,7,GO:0048259,regulation of receptor-mediated endocytosis,1
0,1,3,13,GO:0048265;GO:0033555,multicellular organismal response to stress,1
0,1,4,13,GO:0048285,organelle fission,1
0,1,2,6,GO:0048286,lung alveolus development,1
0,1,4,5,GO:0048311,mitochondrion distribution,1
0,1,3,23,GO:0048477;GO:0007292,female gamete generation,1
0,1,3,11,GO:0048484;GO:0042551,neuron maturation,1
0,1,3,5,GO:0048485,sympathetic nervous system development,1
0,1,3,17,GO:0048489;GO:0097479;GO:0097480;GO:0099003,vesicle-mediated transport in synapse,1
0,1,3,18,GO:0048496,maintenance of animal organ identity,1
0,1,3,16,GO:0048514,blood vessel morphogenesis,1
0,1,2,8,GO:0048525,negative regulation of viral process,1
0,1,2,6,GO:0048557,embryonic digestive tract morphogenesis,1
0,1,6,5,GO:0048596,embryonic camera-type eye morphogenesis,1
0,1,2,41,GO:0048608,reproductive structure development,1
0,1,2,17,GO:0048639,positive regulation of developmental growth,1
0,1,2,10,GO:0048662,negative regulation of smooth muscle cell proliferation,1
0,1,4,10,GO:0048678,response to axon injury,1
0,1,3,5,GO:0048703,embryonic viscerocranium morphogenesis,1
0,1,3,10,GO:0048738,cardiac muscle tissue development,1
0,1,6,13,GO:0048739;GO:0048747;GO:0055013,muscle fiber development,1
0,1,4,10,GO:0048749,compound eye development,1
0,1,2,18,GO:0048771,tissue remodeling,1
0,1,2,9,GO:0048793,pronephros development,1
0,1,3,10,GO:0048806,genitalia development,1
0,1,2,5,GO:0048839,inner ear development,1
0,1,5,8,GO:0048844,artery morphogenesis,1
0,1,2,5,GO:0048853,forebrain morphogenesis,1
0,1,4,12,GO:0048863,stem cell differentiation,1
0,1,2,8,GO:0048864,stem cell development,1
0,1,4,13,GO:0048872,homeostasis of number of cells,1
0,1,2,9,GO:0050435,amyloid-beta metabolic process,1
0,1,2,8,GO:0050673,epithelial cell proliferation,1
0,1,2,20,GO:0050688,regulation of defense response to virus,1
0,1,2,9,GO:0050690,regulation of defense response to virus by virus,1
0,1,2,9,GO:0050691,regulation of defense response to virus by host,1
0,1,4,10,GO:0050707,regulation of cytokine secretion,1
0,1,3,13,GO:0050709;GO:0002792;GO:0051224;GO:1904950,negative regulation of protein transport,1
0,1,6,7,GO:0050715,positive regulation of cytokine secretion,1
0,1,7,5,GO:0050718;GO:0032731;GO:0050706;GO:0050716;GO:0032651;GO:0032732;GO:0050704;GO:0032652,regulation of interleukin-1 beta secretion,1
0,1,4,6,GO:0050731;GO:0050730,regulation of peptidyl-tyrosine phosphorylation,1
0,1,2,7,GO:0050771,negative regulation of axonogenesis,1
0,1,6,17,GO:0050772;GO:0010770,positive regulation of cell morphogenesis involved in differentiation,1
0,1,2,8,GO:0050795,regulation of behavior,1
0,1,6,20,GO:0050796,regulation of insulin secretion,1
0,1,2,6,GO:0050805,negative regulation of synaptic transmission,1
0,1,6,5,GO:0050810,regulation of steroid biosynthetic process,1
0,1,2,8,GO:0050847,progesterone receptor signaling pathway,1
0,1,2,6,GO:0050848,regulation of calcium-mediated signaling,1
0,1,2,23,GO:0050880;GO:0035150;GO:0003018,regulation of tube size,1
0,1,5,11,GO:0050885,neuromuscular process controlling balance,1
0,1,2,23,GO:0050900,leukocyte migration,1
0,1,4,17,GO:0050905,neuromuscular process,1
0,1,3,12,GO:0050906,detection of stimulus involved in sensory perception,1
0,1,2,26,GO:0050920,regulation of chemotaxis,1
0,1,5,6,GO:0050923;GO:0050922,regulation of negative chemotaxis,1
0,1,3,9,GO:0050974;GO:0050982,detection of mechanical stimulus,1
0,1,2,9,GO:0050994,regulation of lipid catabolic process,1
0,1,7,10,GO:0051000;GO:0032770;GO:0050999;GO:0032768,regulation of nitric-oxide synthase activity,1
0,1,2,24,GO:0051047;GO:1903532,positive regulation of secretion,1
0,1,3,10,GO:0051053,negative regulation of DNA metabolic process,1
0,1,3,31,GO:0051054,positive regulation of DNA metabolic process,1
0,1,3,10,GO:0051084;GO:0006458,'de novo' protein folding,1
0,1,2,6,GO:0051085;GO:0061077,chaperone-mediated protein folding,1
0,1,5,49,GO:0051091,positive regulation of DNA-binding transcription factor activity,1
0,1,2,25,GO:0051092,positive regulation of NF-kappaB transcription factor activity,1
0,1,6,9,GO:0051103;GO:0006266,DNA ligation,1
0,1,3,9,GO:0051145,smooth muscle cell differentiation,1
0,1,5,7,GO:0051146,striated muscle cell differentiation,1
0,1,2,15,GO:0051147,regulation of muscle cell differentiation,1
0,1,3,5,GO:0051148,negative regulation of muscle cell differentiation,1
0,1,2,5,GO:0051149,positive regulation of muscle cell differentiation,1
0,1,6,5,GO:0051150,regulation of smooth muscle cell differentiation,1
0,1,3,6,GO:0051156,glucose 6-phosphate metabolic process,1
0,1,3,7,GO:0051180;GO:0051181,cofactor transport,1
0,1,2,13,GO:0051205,protein insertion into membrane,1
0,1,2,19,GO:0051216,cartilage development,1
0,1,4,6,GO:0051220,cytoplasmic sequestering of protein,1
0,1,4,18,GO:0051222;GO:1904951;GO:0050714;GO:0002793,positive regulation of establishment of protein localization,1
0,1,3,16,GO:0051225,spindle assembly,1
0,1,4,131,GO:0051270;GO:0040012,regulation of locomotion,1
0,1,3,6,GO:0051298,centrosome duplication,1
0,1,4,10,GO:0051303;GO:0050000,establishment of chromosome localization,1
0,1,2,46,GO:0051345,positive regulation of hydrolase activity,1
0,1,2,9,GO:0051346,negative regulation of hydrolase activity,1
0,1,2,15,GO:0051353;GO:0051341,regulation of oxidoreductase activity,1
0,1,5,9,GO:0051382;GO:0051383;GO:0007079;GO:0051305;GO:0007080;GO:0051310,mitotic metaphase plate congression,1
0,1,2,10,GO:0051384,response to glucocorticoid,1
0,1,-1,8,GO:0051436,obsolete negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,1
0,1,2,6,GO:0051457,maintenance of protein location in nucleus,1
0,1,2,11,GO:0051489,regulation of filopodium assembly,1
0,1,3,9,GO:0051492;GO:0032231;GO:0110020,regulation of actin filament bundle assembly,1
0,1,2,32,GO:0051592,response to calcium ion,1
0,1,4,5,GO:0051597,response to methylmercury,1
0,1,3,5,GO:0051645,Golgi localization,1
0,1,3,10,GO:0051646,mitochondrion localization,1
0,1,3,25,GO:0051648;GO:0051650,vesicle localization,1
0,1,2,24,GO:0051705,multi-organism behavior,1
0,1,7,5,GO:0051770,positive regulation of nitric-oxide synthase biosynthetic process,1
0,1,2,14,GO:0051781;GO:0051302,regulation of cell division,1
0,1,4,10,GO:0051784,negative regulation of nuclear division,1
0,1,2,5,GO:0051817,modification of morphology or physiology of other organism involved in symbiotic interaction,1
0,1,6,9,GO:0051823,regulation of synapse structural plasticity,1
0,1,2,12,GO:0051881,regulation of mitochondrial membrane potential,1
0,1,5,12,GO:0051893;GO:0090109;GO:1903391;GO:1901888,regulation of adherens junction organization,1
0,1,3,9,GO:0051896,regulation of protein kinase B signaling,1
0,1,4,6,GO:0051897,positive regulation of protein kinase B signaling,1
0,1,2,10,GO:0051924,regulation of calcium ion transport,1
0,1,2,6,GO:0051928,positive regulation of calcium ion transport,1
0,1,7,6,GO:0051930;GO:0051931,regulation of sensory perception of pain,1
0,1,4,20,GO:0051963,regulation of synapse assembly,1
0,1,3,6,GO:0051964,negative regulation of synapse assembly,1
0,1,5,7,GO:0051965,positive regulation of synapse assembly,1
0,1,4,20,GO:0051983,regulation of chromosome segregation,1
0,1,5,6,GO:0051988,regulation of attachment of spindle microtubules to kinetochore,1
0,1,2,26,GO:0055001,muscle cell development,1
0,1,3,14,GO:0055002,striated muscle cell development,1
0,1,3,7,GO:0055003;GO:0030239;GO:0045214;GO:0048769;GO:0030240,myofibril assembly,1
0,1,2,16,GO:0055006,cardiac cell development,1
0,1,5,21,GO:0055008;GO:0060415,muscle tissue morphogenesis,1
0,1,6,7,GO:0055010,ventricular cardiac muscle tissue morphogenesis,1
0,1,2,8,GO:0055081,anion homeostasis,1
0,1,5,16,GO:0055088,lipid homeostasis,1
0,1,2,5,GO:0060026,convergent extension,1
0,1,3,6,GO:0060037,pharyngeal system development,1
0,1,2,17,GO:0060041,retina development in camera-type eye,1
0,1,5,9,GO:0060045;GO:0055023;GO:0060043;GO:0055021;GO:0055025;GO:0060421;GO:0055024;GO:0060420;GO:0045844;GO:0048636;GO:1901863,positive regulation of striated muscle tissue development,1
0,1,4,5,GO:0060047;GO:0003015,heart contraction,1
0,1,6,5,GO:0060048,cardiac muscle contraction,1
0,1,2,8,GO:0060052,neurofilament cytoskeleton organization,1
0,1,4,6,GO:0060059,embryonic retina morphogenesis in camera-type eye,1
0,1,2,35,GO:0060070,canonical Wnt signaling pathway,1
0,1,3,6,GO:0060113;GO:0042490,mechanoreceptor differentiation,1
0,1,6,7,GO:0060122,inner ear receptor cell stereocilium organization,1
0,1,2,5,GO:0060148;GO:0060147,positive regulation of posttranscriptional gene silencing,1
0,1,5,18,GO:0060253;GO:0060251;GO:0048715;GO:0048713;GO:2000974;GO:1905457;GO:2000973;GO:1901533;GO:1905456;GO:1901532;GO:0048711;GO:0045687;GO:0014015,regulation of oligodendrocyte differentiation,1
0,1,6,6,GO:0060324;GO:0060123,regulation of growth hormone secretion,1
0,1,5,14,GO:0060346;GO:0060343;GO:0030501;GO:0070169,positive regulation of biomineral tissue development,1
0,1,2,7,GO:0060348,bone development,1
0,1,2,5,GO:0060349,bone morphogenesis,1
0,1,3,5,GO:0060351,cartilage development involved in endochondral bone morphogenesis,1
0,1,7,5,GO:0060402;GO:0060401,calcium ion transport into cytosol,1
0,1,2,7,GO:0060411,cardiac septum morphogenesis,1
0,1,3,6,GO:0060441;GO:0061304;GO:0061299,epithelial tube branching involved in lung morphogenesis,1
0,1,3,5,GO:0060444,branching involved in mammary gland duct morphogenesis,1
0,1,2,9,GO:0060445,branching involved in salivary gland morphogenesis,1
0,1,5,8,GO:0060484;GO:0060485,mesenchyme development,1
0,1,2,5,GO:0060535;GO:0060536,trachea cartilage morphogenesis,1
0,1,2,5,GO:0060563,neuroepithelial cell differentiation,1
0,1,3,14,GO:0060688,regulation of morphogenesis of a branching structure,1
0,1,2,5,GO:0060948,cardiac vascular smooth muscle cell development,1
0,1,2,7,GO:0060968,regulation of gene silencing,1
0,1,2,5,GO:0060977,coronary vasculature morphogenesis,1
0,1,2,5,GO:0060992,response to fungicide,1
0,1,5,8,GO:0060997;GO:0097061;GO:0099173;GO:0106027,neuron projection organization,1
0,1,5,5,GO:0061035,regulation of cartilage development,1
0,1,2,28,GO:0061041;GO:1903034,regulation of response to wounding,1
0,1,2,26,GO:0061138;GO:0001763;GO:0048754,morphogenesis of a branching epithelium,1
0,1,3,5,GO:0061333,renal tubule morphogenesis,1
0,1,2,7,GO:0061351,neural precursor cell proliferation,1
0,1,2,7,GO:0061448;GO:0060612,connective tissue development,1
0,1,4,6,GO:0061640,cytoskeleton-dependent cytokinesis,1
0,1,3,9,GO:0061982,meiosis I cell cycle process,1
0,1,2,7,GO:0065002;GO:0071806;GO:0044743,intracellular protein transmembrane transport,1
0,1,3,9,GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,1
0,1,2,10,GO:0070192,chromosome organization involved in meiotic cell cycle,1
0,1,2,18,GO:0070206,protein trimerization,1
0,1,2,6,GO:0070207,protein homotrimerization,1
0,1,2,12,GO:0070208,protein heterotrimerization,1
0,1,6,7,GO:0070286;GO:0060285;GO:0060287;GO:0003351;GO:0003341;GO:0060286,cilium-dependent cell motility,1
0,1,4,6,GO:0070293;GO:0003014,renal system process,1
0,1,5,13,GO:0070374;GO:0070372,regulation of ERK1 and ERK2 cascade,1
0,1,4,10,GO:0070509,calcium ion import,1
0,1,3,17,GO:0070536,protein K63-linked deubiquitination,1
0,1,5,8,GO:0070555,response to interleukin-1,1
0,1,2,5,GO:0070828,heterochromatin organization,1
0,1,5,13,GO:0070830;GO:0120192;GO:0120193,tight junction organization,1
0,1,2,46,GO:0070838;GO:0072511,divalent inorganic cation transport,1
0,1,3,5,GO:0070918;GO:0031050,production of small RNA involved in gene silencing by RNA,1
0,1,3,7,GO:0070997,neuron death,1
0,1,5,9,GO:0071044;GO:0008334,histone mRNA metabolic process,1
0,1,8,7,GO:0071108,protein K48-linked deubiquitination,1
0,1,6,15,GO:0071156,regulation of cell cycle arrest,1
0,1,7,13,GO:0071158;GO:2000134;GO:1902807,positive regulation of cell cycle arrest,1
0,1,3,13,GO:0071214;GO:0104004,cellular response to abiotic stimulus,1
0,1,3,14,GO:0071230,cellular response to amino acid stimulus,1
0,1,4,6,GO:0071236,cellular response to antibiotic,1
0,1,2,5,GO:0071260,cellular response to mechanical stimulus,1
0,1,3,5,GO:0071277,cellular response to calcium ion,1
0,1,2,9,GO:0071320;GO:0051591,response to cAMP,1
0,1,2,14,GO:0071345,cellular response to cytokine stimulus,1
0,1,5,15,GO:0071363;GO:0070848,cellular response to growth factor stimulus,1
0,1,3,11,GO:0071364;GO:0070849,response to epidermal growth factor,1
0,1,2,16,GO:0071407,cellular response to organic cyclic compound,1
0,1,3,9,GO:0071456;GO:0036294;GO:0071453,cellular response to oxygen levels,1
0,1,3,8,GO:0071479;GO:0071478,cellular response to radiation,1
0,1,2,21,GO:0071496,cellular response to external stimulus,1
0,1,3,7,GO:0071555;GO:0045229;GO:0071554,cell wall organization,1
0,1,4,12,GO:0071726;GO:0071221;GO:0071724;GO:0070339;GO:0071220;GO:0032493;GO:0042496;GO:0070340;GO:0042494;GO:0032490;GO:0098581;GO:0009595,detection of external biotic stimulus,1
0,1,5,8,GO:0071816;GO:0045048,tail-anchored membrane protein insertion into ER membrane,1
0,1,2,5,GO:0071985,multivesicular body sorting pathway,1
0,1,3,31,GO:0072073,kidney epithelium development,1
0,1,4,7,GO:0072080;GO:0061326;GO:0072009,renal tubule development,1
0,1,2,6,GO:0072089,stem cell proliferation,1
0,1,3,6,GO:0072132,mesenchyme morphogenesis,1
0,1,4,25,GO:0072175;GO:0001838,epithelial tube formation,1
0,1,6,5,GO:0072234;GO:0072170;GO:0072243;GO:0072207,metanephric epithelium development,1
0,1,4,12,GO:0072300;GO:0072216;GO:0072298;GO:0090193;GO:0072215;GO:0090192,regulation of glomerulus development,1
0,1,4,26,GO:0072329,monocarboxylic acid catabolic process,1
0,1,2,27,GO:0072331,signal transduction by p53 class mediator,1
0,1,2,5,GO:0072347,response to anesthetic,1
0,1,2,14,GO:0072384,organelle transport along microtubule,1
0,1,4,7,GO:0072523,purine-containing compound catabolic process,1
0,1,2,20,GO:0072527;GO:0006220,pyrimidine-containing compound metabolic process,1
0,1,2,14,GO:0072528;GO:0006221,pyrimidine-containing compound biosynthetic process,1
0,1,2,9,GO:0072529;GO:0046135;GO:0006213,pyrimidine-containing compound catabolic process,1
0,1,6,14,GO:0072655;GO:0070585,protein localization to mitochondrion,1
0,1,5,75,GO:0072657,protein localization to membrane,1
0,1,4,14,GO:0090084;GO:0090083,negative regulation of inclusion body assembly,1
0,1,4,19,GO:0090090,negative regulation of canonical Wnt signaling pathway,1
0,1,3,21,GO:0090100;GO:0030513,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1
0,1,4,7,GO:0090103,cochlea morphogenesis,1
0,1,2,50,GO:0090150,establishment of protein localization to membrane,1
0,1,2,15,GO:0090162,establishment of epithelial cell polarity,1
0,1,6,8,GO:0090175,regulation of establishment of planar polarity,1
0,1,2,18,GO:0090184;GO:0090183,regulation of kidney development,1
0,1,2,14,GO:0090208;GO:0090207,regulation of triglyceride metabolic process,1
0,1,5,8,GO:0090257,regulation of muscle system process,1
0,1,3,29,GO:0090276;GO:0046883,regulation of hormone secretion,1
0,1,3,6,GO:0090277;GO:0046887,positive regulation of hormone secretion,1
0,1,2,5,GO:0090307,mitotic spindle assembly,1
0,1,2,15,GO:0090329,regulation of DNA-dependent DNA replication,1
0,1,2,6,GO:0090342,regulation of cell aging,1
0,1,2,8,GO:0097039,protein linear polyubiquitination,1
0,1,3,8,GO:0097084,vascular smooth muscle cell development,1
0,1,3,7,GO:0097150,neuronal stem cell population maintenance,1
0,1,3,33,GO:0097164,ammonium ion metabolic process,1
0,1,2,17,GO:0097193;GO:0097190;GO:0008630,intrinsic apoptotic signaling pathway,1
0,1,2,13,GO:0097305,response to alcohol,1
0,1,4,12,GO:0097746;GO:0035296,regulation of tube diameter,1
0,1,1,17,GO:0098743,cell aggregation,1
0,1,3,9,GO:0098815;GO:0071625,modulation of excitatory postsynaptic potential,1
0,1,3,7,GO:0098930,axonal transport,1
0,1,3,5,GO:0099120,socially cooperative development,1
0,1,3,11,GO:0110110,positive regulation of animal organ morphogenesis,1
0,1,2,9,GO:0110111,negative regulation of animal organ morphogenesis,1
0,1,2,18,GO:0120032;GO:0060491,regulation of plasma membrane bounded cell projection assembly,1
0,1,3,6,GO:1901068,guanosine-containing compound metabolic process,1
0,1,4,7,GO:1901654,response to ketone,1
0,1,4,10,GO:1901661,quinone metabolic process,1
0,1,4,25,GO:1901988;GO:1901991,negative regulation of cell cycle phase transition,1
0,1,4,41,GO:1901990;GO:1901987,regulation of cell cycle phase transition,1
0,1,3,7,GO:1902275,regulation of chromatin organization,1
0,1,3,15,GO:1902692;GO:0072091;GO:2000177,regulation of neural precursor cell proliferation,1
0,1,3,15,GO:1902806;GO:2000045,regulation of G1/S transition of mitotic cell cycle,1
0,1,3,5,GO:1903169,regulation of calcium ion transmembrane transport,1
0,1,6,10,GO:1903305,regulation of regulated secretory pathway,1
0,1,4,8,GO:1903313,positive regulation of mRNA metabolic process,1
0,1,2,7,GO:1903409,reactive oxygen species biosynthetic process,1
0,1,4,5,GO:1903510,mucopolysaccharide metabolic process,1
0,1,5,12,GO:1903524;GO:1903522,regulation of blood circulation,1
0,1,4,17,GO:1903531;GO:0051048,negative regulation of secretion by cell,1
0,1,6,14,GO:1904064;GO:0034767;GO:0034765;GO:0034764;GO:1904062,positive regulation of transmembrane transport,1
0,1,3,7,GO:1905039;GO:0098656;GO:1903825,carboxylic acid transmembrane transport,1
0,1,2,18,GO:1905952,regulation of lipid localization,1
0,1,2,11,GO:1990542,mitochondrial transmembrane transport,1
0,1,2,5,GO:2000107;GO:2000106,negative regulation of leukocyte apoptotic process,1
0,1,2,97,GO:2000145;GO:0030334,regulation of cell motility,1
0,1,2,7,GO:2000178,negative regulation of neural precursor cell proliferation,1
0,1,2,5,GO:2000242,negative regulation of reproductive process,1
0,1,3,8,GO:2000273;GO:0010469,regulation of signaling receptor activity,1
0,1,2,5,GO:2000379,positive regulation of reactive oxygen species metabolic process,1
0,1,3,9,GO:2000736,regulation of stem cell differentiation,1
0,1,2,10,GO:2001251,negative regulation of chromosome organization,1
0,1,2,5,GO:2001252,positive regulation of chromosome organization,1
0,1,5,8,GO:2001259;GO:2001257;GO:0032414;GO:0032412,regulation of ion transmembrane transporter activity,1
0,0.285692802,2,42,GO:0000398;GO:0000377;GO:0000375,RNA splicing,
0,0.000926994,6,35,GO:0006352,DNA-templated transcription,
0,0.35080479,4,13,GO:0007188;GO:0007187,G protein-coupled receptor signaling pathway,
0,0.16982022,2,5,GO:0035249,synaptic transmission,
0,0.230279858,2,37,GO:0040029,regulation of gene expression,
0,0.136171282,4,5,GO:0040034,regulation of development,
0,0.14791215,2,11,GO:0042147,retrograde transport,
0,0.116215175,2,6,GO:0046529,imaginal disc fusion,
0,0.421591148,5,22,GO:0050792;GO:0043903,regulation of symbiosis,
0,1,-1,5,GO:0000059,obsolete protein import into nucleus,
0,1,-1,6,GO:0000060,obsolete protein import into nucleus,
0,1,2,33,GO:0000184,nuclear-transcribed mRNA catabolic process,
0,1,2,18,GO:0000381,regulation of alternative mRNA splicing,
0,1,6,14,GO:0006313;GO:0032196,transposition,
0,1,5,14,GO:0006353,DNA-templated transcription,
0,1,2,15,GO:0006368;GO:0006354,DNA-templated transcription,
0,1,2,10,GO:0006890,retrograde vesicle-mediated transport,
0,1,6,7,GO:0006930,substrate-dependent cell migration,
0,1,2,9,GO:0006958,complement activation,
0,1,4,12,GO:0015986;GO:0015985,energy coupled proton transport,
0,1,2,14,GO:0032784,regulation of DNA-templated transcription,
0,1,2,7,GO:0032786,positive regulation of DNA-templated transcription,
0,1,3,7,GO:0035152,regulation of tube architecture,
0,1,6,7,GO:0035641;GO:0045794;GO:2000969;GO:1900451;GO:2000311;GO:1900449;GO:0099601;GO:2000463;GO:0051835;GO:0051968;GO:0097107;GO:0097106;GO:0098698;GO:0099084;GO:2000822;GO:1903365;GO:0021773;GO:0021879,positive regulation of synaptic transmission,
0,1,2,9,GO:0051966,regulation of synaptic transmission,
0,1,3,5,GO:0060071,Wnt signaling pathway,